Hercules Capital Inc
For the period ended Dec 31, 2023. Filed Feb 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Schedule of Investments as of December 31,
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Debt Investments | ||||||||
| Biotechnology Tools | ||||||||
| Alamar Biosciences, Inc. | Senior Secured | June 2026 | Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee | $15,049 | $15,069 | $15,508 | (13)(14) | |
| PathAI, Inc. | Senior Secured | January 2027 | Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee | $32,000 | 31,941 | 32,519 | (12) | |
| Subtotal: Biotechnology Tools (2.66%)* | 47,010 | 48,027 | ||||||
| Communications & Networking | ||||||||
| Aryaka Networks, Inc. | Senior Secured | July 2026 | Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee | $25,153 | 24,943 | 26,000 | (12)(14)(19) | |
| Cytracom Holdings LLC | Senior Secured | February 2025 | 3-month SOFR + 9.72%, Floor rate 10.62% | $3,267 | 3,239 | 3,272 | (11)(17)(18) | |
| Subtotal: Communications & Networking (1.62%)* | 28,182 | 29,272 | ||||||
| Consumer & Business Services | ||||||||
| Altumint, Inc. | Senior Secured | December 2027 | Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee | $10,000 | 9,905 | 9,905 | (15)(17) | |
| AppDirect, Inc. | Senior Secured | April 2026 | Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee | $55,790 | 57,653 | 59,507 | (12) | |
| Carwow LTD | Senior Secured | December 2024 | Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee | £19,146 | 26,834 | 25,157 | (5)(10)(14) | |
| Houzz, Inc. | Convertible Debt | May 2028 | PIK Interest 8.50% | $23,340 | 23,340 | 23,244 | (9)(14) | |
| Jobandtalent USA, Inc. | Senior Secured | February 2025 | 1-month SOFR + 8.86% Floor rate 9.75%, 3.00% Exit Fee | $14,000 | 14,095 | 14,259 | (5)(10) | |
| Plentific Ltd | Senior Secured | October 2026 | Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee | $875 | 853 | 853 | (5)(10)(17) | |
| Provi | Senior Secured | December 2026 | Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee | $15,000 | 14,904 | 15,046 | (15) | |
| Rhino Labs, Inc. | Senior Secured | June 2024 | Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% | $4,710 | 4,704 | 4,704 | (14)(15) | |
| Riviera Partners LLC | Senior Secured | April 2027 | 3-month SOFR + 8.26%, Floor rate 9.26% | $36,868 | 36,339 | 34,659 | (17)(18) | |
| RVShare, LLC | Senior Secured | December 2026 | 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% | $28,876 | 28,404 | 28,888 | (13)(14)(15) | |
| SeatGeek, Inc. | Senior Secured | May 2026 | Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee | $25,199 | 25,126 | 25,869 | (11)(14)(16) | |
| Senior Secured | July 2026 | Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee | $77,642 | 77,170 | 79,119 | (12)(14)(16) | ||
| Total SeatGeek, Inc. | $102,841 | 102,296 | 104,988 | |||||
| Skyword, Inc. | Senior Secured | November 2026 | Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee | $9,169 | 9,189 | 9,311 | (13)(14) | |
| Tectura Corporation | Senior Secured | July 2024 | FIXED 8.25% | $8,250 | 8,250 | 8,250 | (7) | |
| Thumbtack, Inc. | Senior Secured | April 2026 | Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee | $10,258 | 10,317 | 10,639 | (12)(14)(17) | |
| Udacity, Inc. | Senior Secured | September 2024 | Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee | $53,000 | 53,989 | 53,130 | (12)(14) | |
| Veem, Inc. | Senior Secured | March 2025 | Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee | $5,107 | 5,176 | 5,230 | (13)(14) | |
| Senior Secured | March 2025 | Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee | $5,110 | 5,189 | 5,286 | (12)(14) | ||
| Total Veem, Inc. | $10,217 | 10,365 | 10,516 | |||||
| Worldremit Group Limited | Senior Secured | February 2025 | 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee | $88,250 | 89,318 | 89,653 | (5)(10)(11)(12)(16) (19) | |
| Senior Secured | February 2025 | 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee | $6,250 | 6,308 | 6,344 | (5)(10)(16)(19) | ||
| Total Worldremit Group Limited | $94,500 | 95,626 | 95,997 | |||||
| Subtotal: Consumer & Business Services (28.24%)* | 507,063 | 509,053 | ||||||
| Diversified Financial Services | ||||||||
| Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC) | Unsecured | September 2026 | FIXED 11.50% | $25,000 | 24,663 | 24,663 | (7)(20) | |
| Unsecured | September 2026 | FIXED 11.95% | $10,000 | 9,815 | 9,815 | (7)(20) | ||
| Total Gibraltar Acquisition, LLC | $35,000 | 34,478 | 34,478 | |||||
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Hercules Adviser LLC | Unsecured | June 2025 | FIXED 5.00% | $12,000 | $12,000 | $12,000 | (7)(23) | |
| Next Insurance, Inc. | Senior Secured | February 2028 | Prime - (1.50%), Floor rate 4.75%, PIK Interest 5.50% | $10,469 | 10,286 | 10,618 | (14)(17)(19) | |
| Subtotal: Diversified Financial Services (3.17%)* | 56,764 | 57,096 | ||||||
| Drug Discovery & Development | ||||||||
| Akero Therapeutics, Inc. | Senior Secured | January 2027 | Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee | $12,500 | 12,525 | 13,065 | (10)(13)(17) | |
| Aldeyra Therapeutics, Inc. | Senior Secured | October 2024 | Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee | $15,000 | 15,152 | 15,152 | (11) | |
| Alladapt Immunotherapeutics Inc. | Senior Secured | September 2026 | Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee | $35,000 | 35,173 | 36,855 | (13) | |
| AmplifyBio, LLC | Senior Secured | January 2027 | Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee | $24,000 | 24,120 | 24,514 | (15) | |
| ATAI Life Sciences N.V. | Senior Secured | August 2026 | Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee | $10,500 | 10,695 | 10,904 | (5)(10) | |
| Axsome Therapeutics, Inc. | Senior Secured | January 2028 | Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee | $143,350 | 143,646 | 150,255 | (10)(11)(12)(16) | |
| Bicycle Therapeutics PLC | Senior Secured | July 2025 | Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee | $11,500 | 11,880 | 11,783 | (5)(10)(11)(12) | |
| BiomX, INC | Senior Secured | September 2025 | Prime +5.70%, Floor rate 8.95%, 6.55% Exit Fee | $6,448 | 6,807 | 6,790 | (5)(10)(11) | |
| Braeburn, Inc. | Senior Secured | October 2028 | Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee | $52,601 | 52,185 | 52,185 | (14) | |
| BridgeBio Pharma, Inc. | Senior Secured | November 2026 | FIXED 9.00%, 2.00% Exit Fee | $38,167 | 38,124 | 35,498 | (12)(13)(14) | |
| Cellarity, Inc. | Senior Secured | June 2026 | Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee | $29,193 | 29,482 | 30,051 | (13)(15) | |
| COMPASS Pathways plc | Senior Secured | July 2027 | Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee | $24,144 | 23,798 | 24,601 | (5)(10)(14) | |
| Corium, Inc. | Senior Secured | September 2026 | Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee | $105,225 | 107,667 | 108,545 | (13)(16) | |
| Curevo, Inc. | Senior Secured | June 2027 | Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee | $10,000 | 9,821 | 10,076 | (15) | |
| Eloxx Pharmaceuticals, Inc. | Senior Secured | April 2025 | Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee | $3,099 | 3,789 | 3,731 | (15) | |
| enGene, Inc. | Senior Secured | January 2028 | Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee | $15,750 | 15,550 | 15,550 | (5)(10) | |
| G1 Therapeutics, Inc. | Senior Secured | November 2026 | Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee | $38,750 | 39,679 | 40,421 | (11)(12)(15) | |
| Geron Corporation | Senior Secured | April 2025 | Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee | $30,200 | 31,005 | 31,210 | (10)(12)(13) | |
| Gritstone Bio, Inc. | Senior Secured | July 2027 | Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee | $30,532 | 30,717 | 30,909 | (13)(14) | |
| Heron Therapeutics, Inc. | Senior Secured | February 2026 | Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee | $20,095 | 19,788 | 19,788 | (14)(15)(17) | |
| Hibercell, Inc. | Senior Secured | May 2025 | Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee | $12,535 | 13,117 | 13,181 | (13)(15) | |
| HilleVax, Inc. | Senior Secured | May 2027 | Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee | $20,524 | 20,685 | 20,335 | (14)(15) | |
| Kura Oncology, Inc. | Senior Secured | November 2027 | Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee | $5,500 | 5,532 | 5,752 | (10)(15)(17) | |
| Locus Biosciences, Inc. | Senior Secured | July 2025 | Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee | $5,399 | 5,651 | 5,686 | (15) | |
| Madrigal Pharmaceutical, Inc. | Senior Secured | May 2026 | Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee | $78,200 | 78,728 | 81,945 | (10) | |
| Phathom Pharmaceuticals, Inc. | Senior Secured | December 2027 | Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee | $129,699 | 130,934 | 128,326 | (10)(12)(14)(15)(16) (17)(22) | |
| Redshift Bioanalytics, Inc. | Senior Secured | January 2026 | Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee | $5,000 | 5,047 | 5,119 | (15) | |
| Replimune Group, Inc. | Senior Secured | October 2027 | Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee | $31,416 | 31,450 | 32,702 | (10)(12)(14) | |
| Tarsus Pharmaceuticals, Inc. | Senior Secured | February 2027 | Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee | $12,375 | 12,488 | 12,916 | (10)(13)(17) | |
| TG Therapeutics, Inc. | Senior Secured | January 2026 | Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee | $65,770 | 66,439 | 67,610 | (10)(11)(12)(14) | |
| uniQure B.V. | Senior Secured | January 2027 | Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee | $70,000 | 71,157 | 73,318 | (5)(10)(11)(12) | |
| Valo Health, LLC | Senior Secured | May 2024 | Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee | $2,396 | 2,808 | 2,808 | (11)(13) | |
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Verona Pharma, Inc. | Senior Secured | December 2028 | 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee | $15,750 | $15,646 | $15,646 | (5)(10) | |
| Viridian Therapeutics, Inc. | Senior Secured | October 2026 | Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee | $8,000 | 8,057 | 8,023 | (10)(13) | |
| X4 Pharmaceuticals, Inc. | Senior Secured | October 2026 | Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee | $55,000 | 54,680 | 55,417 | (11)(12)(13) | |
| Subtotal: Drug Discovery & Development (66.60%)* | 1,184,022 | 1,200,667 | ||||||
| Electronics & Computer Hardware | ||||||||
| Locus Robotics Corp. | Senior Secured | June 2026 | Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee | $18,281 | 18,348 | 18,982 | (19) | |
| Subtotal: Electronics & Computer Hardware (1.05%)* | 18,348 | 18,982 | ||||||
| Healthcare Services, Other | ||||||||
| Better Therapeutics, Inc. | Senior Secured | August 2025 | Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee | $10,865 | 11,285 | 8,455 | (15) | |
| Blue Sprig Pediatrics, Inc. | Senior Secured | November 2026 | 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% | $69,032 | 68,277 | 68,393 | (11)(13)(14) | |
| Carbon Health Technologies, Inc. | Senior Secured | March 2025 | Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee | $46,125 | 47,193 | 46,242 | (11)(13) | |
| Equality Health, LLC | Senior Secured | February 2026 | Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% | $54,425 | 54,142 | 54,697 | (11)(12)(14) | |
| Main Street Rural, Inc. | Senior Secured | July 2027 | Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee | $24,500 | 24,476 | 24,929 | (15)(17) | |
| Modern Life, Inc. | Senior Secured | February 2027 | Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee | $13,000 | 12,888 | 13,111 | (13)(17) | |
| Recover Together, Inc. | Senior Secured | July 2027 | Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee | $35,000 | 34,683 | 34,683 | ||
| Strive Health Holdings, LLC | Senior Secured | September 2027 | Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee | $12,000 | 11,868 | 11,868 | (15) | |
| Vida Health, Inc. | Senior Secured | March 2026 | 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | $36,500 | 36,352 | 36,145 | (11) | |
| Subtotal: Healthcare Services, Other (16.56%)* | 301,164 | 298,523 | ||||||
| Information Services | ||||||||
| Capella Space Corp. | Senior Secured | November 2025 | Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee | $20,477 | 21,166 | 21,351 | (14)(15) | |
| Checkr Group, Inc. | Senior Secured | August 2028 | Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee | $47,621 | 47,460 | 49,382 | (14)(17) | |
| Saama Technologies, LLC | Senior Secured | July 2027 | Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee | $11,725 | 11,627 | 11,876 | (14)(17) | |
| Signal Media Limited | Senior Secured | June 2025 | Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee | $5,400 | 5,364 | 5,392 | (5)(10) | |
| Yipit, LLC | Senior Secured | September 2026 | 1-month SOFR + 8.45%, Floor rate 9.35% | $31,875 | 31,482 | 31,875 | (17)(18) | |
| Subtotal: Information Services (6.65%)* | 117,099 | 119,876 | ||||||
| Manufacturing Technology | ||||||||
| Bright Machines, Inc. | Senior Secured | May 2025 | Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee | $7,827 | 8,064 | 8,006 | (13) | |
| Subtotal: Manufacturing Technology (0.44%)* | 8,064 | 8,006 | ||||||
| Media/Content/Info | ||||||||
| Fever Labs, Inc. | Senior Secured | September 2026 | Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee | $6,667 | 6,672 | 6,768 | (19) | |
| Senior Secured | September 2025 | Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee | $1,167 | 1,178 | 1,188 | (19) | ||
| Senior Secured | December 2025 | Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee | $1,333 | 1,342 | 1,351 | (19) | ||
| Senior Secured | March 2026 | Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee | $1,500 | 1,501 | 1,509 | (19) | ||
| Senior Secured | June 2026 | Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee | $1,667 | 1,647 | 1,653 | (19) | ||
| Total Fever Labs, Inc. | $12,334 | 12,340 | 12,469 | |||||
| Subtotal: Media/Content/Info (0.69%)* | 12,340 | 12,469 | ||||||
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Medical Devices & Equipment | ||||||||
| Senseonics Holdings, Inc. | Senior Secured | September 2027 | Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee | $21,875 | $21,572 | $21,572 | (17) | |
| Subtotal: Medical Devices & Equipment (1.20%)* | 21,572 | 21,572 | ||||||
| Software | ||||||||
| 3GTMS, LLC | Senior Secured | February 2025 | 3-month SOFR + 9.70%, Floor rate 10.60% | $13,110 | 13,029 | 13,103 | (11)(17)(18) | |
| Senior Secured | February 2025 | 3-month SOFR + 6.88%, Floor rate 7.78% | $1,990 | 1,988 | 1,986 | (17)(18) | ||
| Total 3GTMS, LLC | $15,100 | 15,017 | 15,089 | |||||
| Agilence, Inc. | Senior Secured | October 2026 | 1-month BSBY + 9.00%, Floor rate 10.00% | $9,212 | 9,040 | 9,212 | (12)(17)(18) | |
| Alchemer LLC | Senior Secured | May 2028 | 1-month SOFR + 8.14%, Floor rate 9.14% | $20,908 | 20,508 | 21,297 | (13)(17)(18) | |
| Allvue Systems, LLC | Senior Secured | September 2029 | 6-month SOFR + 7.25%, Floor rate 8.25% | $36,410 | 35,530 | 35,530 | (17) | |
| Annex Cloud | Senior Secured | February 2027 | 1-month BSBY + 9.41%, Floor rate 10.41% | $9,823 | 9,649 | 9,761 | (13)(17) | |
| Automation Anywhere, Inc. | Senior Secured | September 2027 | Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee | $19,600 | 19,345 | 20,269 | (11)(17)(19) | |
| Babel Street | Senior Secured | December 2027 | 3-month SOFR + 7.89%, Floor rate 8.89% | $45,000 | 43,983 | 44,928 | (15)(17)(18) | |
| Brain Corporation | Senior Secured | April 2026 | Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee | $30,415 | 30,678 | 30,989 | (13)(14)(15)(17) | |
| Campaign Monitor Limited | Senior Secured | November 2025 | 3-month SOFR + 9.05%, Floor rate 9.90% | $33,000 | 32,706 | 33,000 | (13)(19) | |
| Catchpoint Systems, Inc. | Senior Secured | November 2025 | 3-month SOFR + 9.41%, Floor rate 11.81% | $10,073 | 9,931 | 9,940 | (18) | |
| Ceros, Inc. | Senior Secured | September 2026 | 6-month SOFR + 8.99%, Floor rate 9.89% | $22,867 | 22,498 | 23,075 | (17)(18) | |
| Constructor.io Corporation | Senior Secured | July 2027 | 1-month SOFR + 8.44%, Floor rate 9.44% | $4,688 | 4,592 | 4,790 | (13)(17)(18) | |
| Convoy, Inc. | Senior Secured | March 2026 | Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee | $31,049 | 30,916 | — | (8)(14)(19) | |
| Copper CRM, Inc | Senior Secured | March 2025 | Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee | $9,141 | 9,307 | 9,153 | (11)(14) | |
| Cutover, Inc. | Senior Secured | October 2025 | Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee | $5,500 | 5,544 | 5,715 | (5)(10)(12)(17) | |
| Cybermaxx Intermediate Holdings, Inc. | Senior Secured | August 2026 | 6-month SOFR + 8.63%, Floor rate 9.38% | $7,955 | 7,830 | 7,778 | (13)(17) | |
| Senior Secured | August 2026 | 6-month SOFR + 12.36%, Floor rate 13.11% | $2,546 | 2,494 | 2,556 | (17) | ||
| Total Cybermaxx Intermediate Holdings, Inc. | $10,501 | 10,324 | 10,334 | |||||
| Dashlane, Inc. | Senior Secured | December 2027 | Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee | $42,863 | 43,087 | 43,087 | (11)(13)(17)(19) | |
| Dispatch Technologies, Inc. | Senior Secured | April 2028 | 3-month SOFR + 8.01%, Floor rate 8.76% | $8,125 | 7,949 | 8,127 | (17)(18) | |
| DroneDeploy, Inc. | Senior Secured | July 2026 | Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee | $6,250 | 6,083 | 6,153 | (17) | |
| Eigen Technologies Ltd. | Senior Secured | April 2025 | Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee | $3,750 | 3,801 | 3,730 | (5)(10) | |
| Elation Health, Inc. | Senior Secured | March 2026 | Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee | $12,629 | 12,253 | 12,692 | (14)(17)(19) | |
| Enmark Systems, Inc. | Senior Secured | September 2026 | 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13% | $8,363 | 8,230 | 8,363 | (11)(14)(17)(18) | |
| Flight Schedule Pro, LLC | Senior Secured | October 2027 | 1-month SOFR + 7.80%, Floor rate 8.70% | $6,587 | 6,420 | 6,553 | (17)(18) | |
| Fortified Health Security | Senior Secured | December 2027 | 1-month SOFR + 7.64%, Floor rate 8.54% | $7,000 | 6,851 | 6,910 | (11)(17)(18) | |
| iGrafx, LLC | Senior Secured | May 2027 | 1-month SOFR + 8.66%, Floor rate 9.56% | $5,000 | 4,901 | 4,901 | (18) | |
| Ikon Science Limited | Senior Secured | October 2024 | 3-month SOFR + 9.26%, Floor rate 10.00% | $6,213 | 6,148 | 6,148 | (5)(10)(17)(18) | |
| Khoros (p.k.a Lithium Technologies) | Senior Secured | January 2025 | 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% | $57,770 | 57,730 | 56,293 | (14) | |
| Leapwork ApS | Senior Secured | February 2026 | Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee | $3,813 | 3,810 | 3,907 | (5)(10)(12)(14)(17) | |
| LinenMaster, LLC | Senior Secured | August 2028 | 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% | $15,083 | 14,799 | 14,799 | (14)(17) | |
| Loftware, Inc. | Senior Secured | March 2028 | 3-month SOFR + 7.88%, Floor rate 8.88% | $26,469 | 25,897 | 26,566 | (17)(18) | |
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| LogicSource | Senior Secured | July 2027 | 3-month SOFR + 8.93%, Floor rate 9.93% | $13,300 | $13,074 | $13,493 | (17)(18) | |
| Mobile Solutions Services | Senior Secured | December 2025 | 6-month SOFR + 9.31%, Floor rate 10.06% | $18,366 | 18,116 | 18,176 | (18) | |
| New Relic, Inc. | Senior Secured | November 2030 | 3-month SOFR + 6.75%, Floor rate 7.75% | $20,890 | 20,375 | 20,375 | (17) | |
| Omeda Holdings, LLC | Senior Secured | July 2027 | 3-month SOFR + 8.05%, Floor rate 9.05% | $7,706 | 7,508 | 7,702 | (11)(17)(18) | |
| Onna Technologies, Inc. | Senior Secured | March 2026 | Prime + 1.35%, Floor rate 8.85%, PIK Interest 1.75%, 4.45% Exit Fee | $3,853 | 3,814 | 3,810 | (14) | |
| Salary.com, LLC | Senior Secured | September 2027 | 3-month SOFR + 8.00%, Floor rate 9.00% | $22,185 | 21,814 | 22,048 | (18) | |
| ShadowDragon, LLC | Senior Secured | December 2026 | 1-month SOFR + 9.01%, Floor rate 9.91% | $6,000 | 5,883 | 5,921 | (17)(18) | |
| Simon Data, Inc. | Senior Secured | March 2027 | Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee | $15,065 | 14,982 | 15,037 | (12)(14) | |
| Sisense Ltd. | Senior Secured | July 2027 | Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee | $34,830 | 34,584 | 34,881 | (5)(10)(14) | |
| Streamline Healthcare Solutions | Senior Secured | March 2028 | 3-month SOFR + 7.25%, Floor rate 8.25% | $13,200 | 12,953 | 13,327 | (17)(18) | |
| Sumo Logic, Inc. | Senior Secured | May 2030 | 3-month SOFR + 6.50%, Floor rate 7.50% | $23,000 | 22,460 | 23,105 | (17) | |
| Suzy, Inc. | Senior Secured | August 2027 | Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee | $12,064 | 11,837 | 11,837 | (14)(15)(17) | |
| ThreatConnect, Inc. | Senior Secured | May 2026 | 6-month SOFR + 9.25%, Floor rate 10.00% | $10,920 | 10,730 | 10,920 | (17)(18) | |
| Tipalti Solutions Ltd. | Senior Secured | April 2027 | Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee | $10,649 | 10,578 | 10,835 | (5)(10)(14)(17) | |
| Zappi, Inc. | Senior Secured | December 2027 | 3-month SOFR + 8.03%, Floor rate 9.03% | $9,000 | 8,816 | 8,967 | (5)(10)(13)(17)(18) | |
| Zimperium, Inc. | Senior Secured | May 2027 | 3-month SOFR + 8.31%, Floor rate 9.31% | $16,313 | 16,057 | 16,394 | (17)(18) | |
| Subtotal: Software (40.39%)* | 751,108 | 728,139 | ||||||
| Sustainable and Renewable Technology | ||||||||
| Ampion, PBC | Senior Secured | May 2025 | Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee | $3,926 | 3,952 | 3,939 | (13)(14) | |
| Pineapple Energy LLC | Senior Secured | June 2027 | FIXED 10.00% | $1,682 | 1,682 | 1,678 | (19) | |
| Subtotal: Sustainable and Renewable Technology (0.31%)* | 5,634 | 5,617 | ||||||
| Total: Debt Investments (169.59%)* | $3,058,370 | $3,057,299 | ||||||
| Portfolio Company | Type ofInvestment | Acquisition Date(4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Equity Investments | |||||||
| Consumer & Business Products | |||||||
| Fabletics, Inc. | Equity | 4/30/2010 | Common Stock | 42,989 | $128 | $96 | |
| Equity | 7/16/2013 | Preferred Series B | 130,191 | 1101 | 700 | ||
| Total Fabletics, Inc. | 173,180 | 1,229 | 796 | ||||
| Grove Collaborative, Inc. | Equity | 4/30/2021 | Common Stock | 12,260 | 433 | 21 | (4) |
| Savage X Holding, LLC | Equity | 4/30/2010 | Class A Units | 172,328 | 13 | 863 | |
| TFG Holding, Inc. | Equity | 4/30/2010 | Common Stock | 173,180 | 89 | 584 | |
| Subtotal: Consumer & Business Products (0.13%)* | 1,764 | 2,264 | |||||
| Consumer & Business Services | |||||||
| Carwow LTD | Equity | 12/15/2021 | Preferred Series D-4 | 199,742 | 1,151 | 679 | (5)(10) |
| DoorDash, Inc. | Equity | 12/20/2018 | Common Stock | 56,996 | 657 | 5,636 | (4) |
| Lyft, Inc. | Equity | 12/26/2018 | Common Stock | 100,738 | 5,263 | 1,510 | (4) |
| Nerdy Inc. | Equity | 9/17/2021 | Common Stock | 100,000 | 1,000 | 343 | (4) |
| OfferUp, Inc. | Equity | 10/25/2016 | Preferred Series A | 286,080 | 1,663 | 377 | |
| Portfolio Company | Type ofInvestment | Acquisition Date(4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Equity | 10/25/2016 | Preferred Series A-1 | 108,710 | $632 | $143 | ||
| Total OfferUp, Inc. | 394,790 | 2,295 | 520 | ||||
| Oportun | Equity | 6/28/2013 | Common Stock | 48,365 | 577 | 189 | (4) |
| Reischling Press, Inc. | Equity | 7/31/2020 | Common Stock | 3,095 | 39 | — | |
| Rhino Labs, Inc. | Equity | 1/24/2022 | Common Stock | 7,063 | 1,000 | 559 | |
| Tectura Corporation | Equity | 5/23/2018 | Common Stock | 414,994,863 | 900 | 4 | (7) |
| Equity | 6/6/2016 | Preferred Series BB | 1,000,000 | — | 12 | (7) | |
| Equity | 12/29/2023 | Preferred Series C | 3,235,298 | 13,263 | 3,251 | (7) | |
| Total Tectura Corporation | 419,230,161 | 14,163 | 3,267 | ||||
| Subtotal: Consumer & Business Services (0.70%)* | 26,145 | 12,703 | |||||
| Diversified Financial Services | |||||||
| Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC) | Equity | 3/1/2018 | Member Units | 1 | 34,006 | 28,034 | (7)(20) |
| Hercules Adviser LLC | Equity | 3/26/2021 | Member Units | 1 | 35 | 28,713 | (7)(23) |
| Newfront Insurance Holdings, Inc. | Equity | 9/30/2021 | Preferred Series D-2 | 210,282 | 403 | 325 | |
| Subtotal: Diversified Financial Services (3.17%)* | 34,444 | 57,072 | |||||
| Drug Delivery | |||||||
| Aytu BioScience, Inc. | Equity | 3/28/2014 | Common Stock | 680 | 1,500 | 2 | (4) |
| BioQ Pharma Incorporated | Equity | 12/8/2015 | Preferred Series D | 165,000 | 500 | — | |
| PDS Biotechnology Corporation | Equity | 4/6/2015 | Common Stock | 2,498 | 309 | 12 | (4) |
| Talphera, Inc. (p.k.a. AcelRx Pharmaceuticals, Inc.) | Equity | 12/10/2018 | Common Stock | 8,836 | 1,329 | 7 | (4) |
| Subtotal: Drug Delivery (0.00%)* | 3,638 | 21 | |||||
| Drug Discovery & Development | |||||||
| Avalo Therapeutics, Inc. | Equity | 8/19/2014 | Common Stock | 42 | 1,000 | — | (4) |
| Axsome Therapeutics, Inc. | Equity | 5/9/2022 | Common Stock | 127,021 | 4,165 | 10,110 | (4)(10)(16) |
| Bicycle Therapeutics PLC | Equity | 10/5/2020 | Common Stock | 98,100 | 1,871 | 1,774 | (4)(5)(10) |
| BridgeBio Pharma, Inc. | Equity | 6/21/2018 | Common Stock | 231,329 | 2,255 | 9,339 | (4) |
| Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport) | Equity | 4/6/2021 | Common Stock | 134 | 42 | — | (4)(10) |
| Dare Biosciences, Inc. | Equity | 1/8/2015 | Common Stock | 13,550 | 1,000 | 4 | (4) |
| Dynavax Technologies | Equity | 7/22/2015 | Common Stock | 20,000 | 550 | 280 | (4)(10) |
| Gritstone Bio, Inc. | Equity | 10/26/2022 | Common Stock | 442,477 | 1,000 | 903 | (4) |
| Heron Therapeutics, Inc. | Equity | 7/25/2023 | Common Stock | 364,963 | 500 | 620 | (4) |
| Hibercell, Inc. | Equity | 5/7/2021 | Preferred Series B | 3,466,840 | 4,250 | 1,834 | (15) |
| HilleVax, Inc. | Equity | 5/3/2022 | Common Stock | 235,295 | 4,000 | 3,777 | (4) |
| Humanigen, Inc. | Equity | 3/31/2021 | Common Stock | 43,243 | 800 | — | (4)(10) |
| Kura Oncology, Inc. | Equity | 6/16/2023 | Common Stock | 47,826 | 550 | 688 | (4)(10) |
| Madrigal Pharmaceutical, Inc. | Equity | 9/29/2023 | Common Stock | 5,100 | 773 | 1,180 | (4)(10) |
| NorthSea Therapeutics | Equity | 12/15/2021 | Preferred Series C | 983 | 2,000 | 1,427 | (5)(10) |
| Portfolio Company | Type ofInvestment | Acquisition Date(4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Equity | 6/9/2023 | Common Stock | 147,233 | $1,730 | $1,344 | (4)(10)(16) |
| Rocket Pharmaceuticals, Ltd. | Equity | 8/22/2007 | Common Stock | 944 | 1,500 | 28 | (4) |
| Savara, Inc. | Equity | 8/11/2015 | Common Stock | 11,119 | 203 | 52 | (4) |
| Sio Gene Therapies, Inc. | Equity | 2/2/2017 | Common Stock | 16,228 | 1,269 | 6 | (4) |
| Tarsus Pharmaceuticals, Inc. | Equity | 5/5/2022 | Common Stock | 155,555 | 2,100 | 3,150 | (4)(10) |
| uniQure B.V. | Equity | 1/31/2019 | Common Stock | 17,175 | 332 | 116 | (4)(5)(10) |
| Valo Health, LLC | Equity | 12/11/2020 | Preferred Series B | 510,308 | 3,000 | 2,911 | |
| Equity | 10/31/2022 | Preferred Series C | 170,102 | 1,000 | 1,187 | ||
| Total Valo Health, LLC | 680,410 | 4,000 | 4,098 | ||||
| Verge Analytics, Inc. | Equity | 9/6/2023 | Preferred Series C | 208,588 | 1,500 | 1,753 | |
| Viridian Therapeutics, Inc. | Equity | 11/6/2023 | Common Stock | 32,310 | 400 | 704 | (4)(10) |
| X4 Pharmaceuticals, Inc. | Equity | 11/26/2019 | Common Stock | 1,566,064 | 2,945 | 1,313 | (4) |
| Subtotal: Drug Discovery & Development (2.47%)* | 40,735 | 44,500 | |||||
| Electronics & Computer Hardware | |||||||
| Locus Robotics Corp. | Equity | 11/17/2022 | Preferred Series F | 15,116 | 650 | 407 | |
| Skydio, Inc. | Equity | 3/8/2022 | Preferred Series E | 248,900 | 1,500 | 544 | |
| Subtotal: Electronics & Computer Hardware (0.05%)* | 2,150 | 951 | |||||
| Healthcare Services, Other | |||||||
| 23andMe, Inc. | Equity | 3/11/2019 | Common Stock | 825,732 | 5,094 | 754 | (4) |
| Carbon Health Technologies, Inc. | Equity | 3/30/2021 | Preferred Series C | 217,880 | 1,688 | 206 | |
| Subtotal: Healthcare Services, Other (0.05%)* | 6,782 | 960 | |||||
| Information Services | |||||||
| Planet Labs, Inc. | Equity | 6/21/2019 | Common Stock | 547,880 | 615 | 1,353 | (4) |
| Yipit, LLC | Equity | 12/30/2021 | Preferred Series E | 41,021 | 3,825 | 4,890 | |
| Subtotal: Information Services (0.35%)* | 4,440 | 6,243 | |||||
| Medical Devices & Equipment | |||||||
| Coronado Aesthetics, LLC | Equity | 10/15/2021 | Common Units | 180,000 | — | 2 | (7) |
| Equity | 10/15/2021 | Preferred Series A-2 | 5,000,000 | 250 | 260 | (7) | |
| Total Coronado Aesthetics, LLC | 5,180,000 | 250 | 262 | ||||
| Subtotal: Medical Devices & Equipment (0.01%)* | 250 | 262 | |||||
| Semiconductors | |||||||
| Achronix Semiconductor Corporation | Equity | 7/1/2011 | Preferred Series C | 277,995 | 160 | 394 | |
| Subtotal: Semiconductors (0.02%)* | 160 | 394 | |||||
| Software | |||||||
| 3GTMS, LLC | Equity | 8/9/2021 | Common Stock | 1,000,000 | 1,000 | 863 | |
| Black Crow AI, Inc. affiliates | Equity | 3/24/2021 | Preferred Note | 3 | 2,406 | 2,406 | (21) |
| CapLinked, Inc. | Equity | 10/26/2012 | Preferred Series A-3 | 53,614 | 51 | — | |
| Contentful Global, Inc. | Equity | 12/22/2020 | Preferred Series C | 41,000 | 138 | 303 | (5)(10) |
| Portfolio Company | Type ofInvestment | Acquisition Date(4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Equity | 11/20/2018 | Preferred Series D | 108,500 | $500 | $842 | (5)(10) | |
| Total Contentful Global, Inc. | 149,500 | 638 | 1,145 | ||||
| Docker, Inc. | Equity | 11/29/2018 | Common Stock | 20,000 | 4,284 | 636 | |
| Druva Holdings, Inc. | Equity | 10/22/2015 | Preferred Series 2 | 458,841 | 1,000 | 2,752 | |
| Equity | 8/24/2017 | Preferred Series 3 | 93,620 | 300 | 587 | ||
| Total Druva Holdings, Inc. | 552,461 | 1,300 | 3,339 | ||||
| HighRoads, Inc. | Equity | 1/18/2013 | Common Stock | 190 | 307 | — | |
| Leapwork ApS | Equity | 8/25/2023 | Preferred Series B2 | 183,073 | 250 | 231 | (5)(10) |
| Lightbend, Inc. | Equity | 12/4/2020 | Common Stock | 38,461 | 265 | 23 | |
| Nextdoor.com, Inc. | Equity | 8/1/2018 | Common Stock | 1,019,255 | 4,854 | 1,927 | (4) |
| Palantir Technologies | Equity | 9/23/2020 | Common Stock | 568,337 | 3,474 | 9,758 | (4) |
| SingleStore, Inc. | Equity | 11/25/2020 | Preferred Series E | 580,983 | 2,000 | 1,721 | |
| Equity | 8/12/2021 | Preferred Series F | 52,956 | 280 | 196 | ||
| Total SingleStore, Inc. | 633,939 | 2,280 | 1,917 | ||||
| Verana Health, Inc. | Equity | 7/8/2021 | Preferred Series E | 952,562 | 2,000 | 422 | |
| ZeroFox, Inc. | Equity | 5/7/2020 | Common Stock | 289,992 | 101 | 252 | (4) |
| Subtotal: Software (1.27%)* | 23,210 | 22,919 | |||||
| Sustainable and Renewable Technology | |||||||
| Fulcrum Bioenergy, Inc. | Equity | 9/13/2012 | Preferred Series C-1 | 187,265 | 711 | 529 | |
| Impossible Foods, Inc. | Equity | 5/10/2019 | Preferred Series E-1 | 188,611 | 2,000 | 479 | |
| Modumetal, Inc. | Equity | 6/1/2015 | Common Stock | 1,035 | 500 | — | |
| NantEnergy, LLC | Equity | 8/31/2013 | Common Units | 59,665 | 102 | — | |
| Pineapple Energy LLC | Equity | 12/10/2020 | Common Stock | 304,487 | 3,153 | 180 | (4) |
| Pivot Bio, Inc. | Equity | 6/28/2021 | Preferred Series D | 593,080 | 4,500 | 2,684 | |
| Proterra, Inc. | Equity | 5/28/2015 | Common Stock | 457,841 | 542 | 9 | (4) |
| Subtotal: Sustainable and Renewable Technology (0.22%)* | 11,508 | 3,881 | |||||
| Total: Equity Investments (8.44%)* | $155,226 | $152,170 | |||||
| Warrant Investments | |||||||
| Biotechnology Tools | |||||||
| Alamar Biosciences, Inc. | Warrant | 6/21/2022 | Preferred Series B | 46,197 | $36 | $20 | |
| PathAI, Inc. | Warrant | 12/23/2022 | Common Stock | 53,418 | 460 | 334 | (12) |
| Subtotal: Biotechnology Tools (0.02%)* | 496 | 354 | |||||
| Communications & Networking | |||||||
| Aryaka Networks, Inc. | Warrant | 6/28/2022 | Common Stock | 229,611 | 123 | 128 | (12) |
| Subtotal: Communications & Networking (0.01%)* | 123 | 128 | |||||
| Consumer & Business Products | |||||||
| Gadget Guard, LLC | Warrant | 6/3/2014 | Common Stock | 1,662,441 | 228 | — | |
| The Neat Company | Warrant | 8/13/2014 | Common Stock | 54,054 | 365 | — | |
| Portfolio Company · Type ofInvestment · Acquisition Date(4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Whoop, Inc. | Warrant | 6/27/2018 | Preferred Series C | 686,270 | $18 | $325 | ||
| Subtotal: Consumer & Business Products (0.02%)* | 611 | 325 | ||||||
| Consumer & Business Services | ||||||||
| Carwow LTD | Warrant | 12/14/2021 | Common Stock | 174,163 | 164 | 75 | (5)(10) | |
| Houzz, Inc. | Warrant | 10/29/2019 | Common Stock | 529,661 | 20 | — | ||
| Landing Holdings Inc. | Warrant | 3/12/2021 | Common Stock | 11,806 | 116 | 298 | (15) | |
| Lendio, Inc. | Warrant | 3/29/2019 | Preferred Series D | 127,032 | 39 | 33 | ||
| Plentific Ltd | Warrant | 10/3/2023 | Ordinary Shares | 19,499 | 48 | 51 | (5)(10) | |
| Provi | Warrant | 12/22/2022 | Common Stock | 117,042 | 166 | 74 | (15) | |
| Rhino Labs, Inc. | Warrant | 3/12/2021 | Common Stock | 13,106 | 470 | 4 | (15) | |
| SeatGeek, Inc. | Warrant | 6/12/2019 | Common Stock | 1,379,761 | 842 | 3,065 | (16) | |
| Skyword, Inc. | Warrant | 11/14/2022 | Common Stock | 1,607,143 | 57 | 58 | ||
| Warrant | 8/23/2019 | Preferred Series B | 444,444 | 83 | 5 | |||
| Total Skyword, Inc. | 2,051,587 | 140 | 63 | |||||
| Snagajob.com, Inc. | Warrant | 4/20/2020 | Common Stock | 600,000 | 16 | — | ||
| Warrant | 6/30/2016 | Preferred Series A | 1,800,000 | 782 | — | |||
| Warrant | 8/1/2018 | Preferred Series B | 1,211,537 | 62 | — | |||
| Total Snagajob.com, Inc. | 3,611,537 | 860 | — | |||||
| Thumbtack, Inc. | Warrant | 5/1/2018 | Common Stock | 267,225 | 844 | 515 | (12) | |
| Udacity, Inc. | Warrant | 9/25/2020 | Common Stock | 486,359 | 218 | — | (12) | |
| Veem, Inc. | Warrant | 3/31/2022 | Common Stock | 98,428 | 126 | 16 | (12) | |
| Worldremit Group Limited | Warrant | 2/11/2021 | Preferred Series D | 77,215 | 129 | 23 | (5)(10)(12)(16) | |
| Warrant | 8/27/2021 | Preferred Series E | 1,868 | 26 | — | (5)(10)(16) | ||
| Total Worldremit Group Limited | 79,083 | 155 | 23 | |||||
| Subtotal: Consumer & Business Services (0.23%)* | 4,208 | 4,217 | ||||||
| Diversified Financial Services | ||||||||
| Next Insurance, Inc. | Warrant | 2/3/2023 | Common Stock | 522,930 | 214 | 554 | ||
| Subtotal: Diversified Financial Services (0.03%)* | 214 | 554 | ||||||
| Drug Delivery | ||||||||
| Aerami Therapeutics Holdings, Inc. | Warrant | 6/1/2016 | Common Stock | 67,069 | — | — | ||
| BioQ Pharma Incorporated | Warrant | 10/27/2014 | Common Stock | 459,183 | 2 | — | ||
| PDS Biotechnology Corporation | Warrant | 8/28/2014 | Common Stock | 3,929 | 390 | — | (4) | |
| Subtotal: Drug Delivery (0.00%)* | 392 | — | ||||||
| Drug Discovery & Development | ||||||||
| ADMA Biologics, Inc. | Warrant | 2/24/2014 | Common Stock | 58,000 | 166 | 11 | (4) | |
| Akero Therapeutics, Inc. | Warrant | 6/15/2022 | Common Stock | 22,949 | 175 | 335 | (4)(10) | |
| AmplifyBio, LLC | Warrant | 12/27/2022 | Class A Units | 69,239 | 237 | 184 | (15) | |
| Axsome Therapeutics, Inc. | Warrant | 9/25/2020 | Common Stock | 61,004 | 1,290 | 1,657 | (4)(10)(12)(16) | |
| Cellarity, Inc. | Warrant | 12/8/2021 | Preferred Series B | 100,000 | 287 | 201 | (15) | |
| Century Therapeutics, Inc. | Warrant | 9/14/2020 | Common Stock | 16,112 | 37 | 1 | (4) | |
| Portfolio Company | Type ofInvestment | Acquisition Date(4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| COMPASS Pathways plc | Warrant | 6/30/2023 | Ordinary Shares | 75,376 | $278 | $285 | (4)(5)(10) |
| Curevo, Inc. | Warrant | 6/9/2023 | Common Stock | 95,221 | 233 | 251 | (15) |
| Dermavant Sciences Ltd. | Warrant | 5/31/2019 | Common Stock | 223,642 | 101 | 7 | (5)(10) |
| enGene, Inc. | Warrant | 12/22/2023 | Common Stock | 43,689 | 118 | 179 | (4)(5)(10) |
| Evofem Biosciences, Inc. | Warrant | 6/11/2014 | Common Stock | 3 | 266 | — | (4) |
| Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.) | Warrant | 2/18/2016 | Common Stock | 201 | 119 | — | (4) |
| Heron Therapeutics, Inc. | Warrant | 8/9/2023 | Common Stock | 238,095 | 228 | 223 | (4)(15) |
| Kineta, Inc. | Warrant | 12/20/2019 | Common Stock | 2,202 | 110 | — | (4) |
| Kura Oncology, Inc. | Warrant | 11/2/2022 | Common Stock | 14,342 | 88 | 63 | (4)(10)(15) |
| Madrigal Pharmaceutical, Inc. | Warrant | 5/9/2022 | Common Stock | 13,229 | 570 | 1,842 | (4)(10) |
| Phathom Pharmaceuticals, Inc. | Warrant | 9/17/2021 | Common Stock | 64,687 | 848 | 68 | (4)(10)(12)(15)(16) |
| Redshift Bioanalytics, Inc. | Warrant | 3/23/2022 | Preferred Series E | 475,510 | 20 | 6 | (15) |
| Scynexis, Inc. | Warrant | 5/14/2021 | Common Stock | 106,035 | 296 | 28 | (4) |
| TG Therapeutics, Inc. | Warrant | 2/28/2019 | Common Stock | 264,226 | 1,284 | 2,583 | (4)(10)(12) |
| Valo Health, LLC | Warrant | 6/15/2020 | Common Units | 102,216 | 256 | 153 | |
| X4 Pharmaceuticals, Inc. | Warrant | 3/18/2019 | Common Stock | 1,392,787 | 510 | 225 | (4) |
| Subtotal: Drug Discovery & Development (0.46%)* | 7,517 | 8,302 | |||||
| Electronics & Computer Hardware | |||||||
| 908 Devices, Inc. | Warrant | 3/15/2017 | Common Stock | 49,078 | 101 | 175 | (4) |
| Locus Robotics Corp. | Warrant | 6/21/2022 | Common Stock | 8,503 | 34 | 102 | |
| Skydio, Inc. | Warrant | 11/8/2021 | Common Stock | 622,255 | 557 | 114 | |
| Subtotal: Electronics & Computer Hardware (0.02%)* | 692 | 391 | |||||
| Healthcare Services, Other | |||||||
| Modern Life, Inc. | Warrant | 3/30/2023 | Common Stock | 37,618 | 164 | 165 | |
| Recover Together, Inc. | Warrant | 7/3/2023 | Common Stock | 194,830 | 382 | 327 | |
| Strive Health Holdings, LLC | Warrant | 9/28/2023 | Common Units | 51,760 | 83 | 95 | (15) |
| Vida Health, Inc. | Warrant | 3/28/2022 | Common Stock | 192,431 | 121 | 9 | |
| Subtotal: Healthcare Services, Other (0.03%)* | 750 | 596 | |||||
| Information Services | |||||||
| Capella Space Corp. | Warrant | 10/21/2021 | Common Stock | 176,200 | 207 | 33 | (15) |
| INMOBI Inc. | Warrant | 11/19/2014 | Common Stock | 65,587 | 82 | — | (5)(10) |
| NetBase Solutions, Inc. | Warrant | 8/22/2017 | Preferred Series 1 | 60,000 | 356 | 362 | |
| Signal Media Limited | Warrant | 6/29/2022 | Common Stock | 113,828 | 49 | 91 | (5)(10) |
| Subtotal: Information Services (0.03%)* | 694 | 486 | |||||
| Manufacturing Technology | |||||||
| Bright Machines, Inc. | Warrant | 3/31/2022 | Common Stock | 392,308 | 537 | 279 | |
| MacroFab, Inc. | Warrant | 3/23/2022 | Common Stock | 1,111,111 | 528 | 677 | |
| Portfolio Company | Type ofInvestment | Acquisition Date(4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Xometry, Inc. | Warrant | 5/9/2018 | Common Stock | 87,784 | $47 | $2,044 | (4) |
| Subtotal: Manufacturing Technology (0.17%)* | 1,112 | 3,000 | |||||
| Media/Content/Info | |||||||
| Fever Labs, Inc. | Warrant | 12/30/2022 | Preferred Series E-1 | 369,370 | 67 | 235 | |
| Subtotal: Media/Content/Info (0.01%)* | 67 | 235 | |||||
| Medical Devices & Equipment | |||||||
| Intuity Medical, Inc. | Warrant | 12/29/2017 | Preferred Series B-1 | 3,076,323 | 294 | — | |
| Outset Medical, Inc. | Warrant | 9/27/2013 | Common Stock | 62,794 | 401 | 78 | (4) |
| Senseonics Holdings, Inc. | Warrant | 9/8/2023 | Common Stock | 728,317 | 200 | 184 | (4) |
| Tela Bio, Inc. | Warrant | 3/31/2017 | Common Stock | 15,712 | 61 | — | (4) |
| Subtotal: Medical Devices & Equipment (0.01%)* | 956 | 262 | |||||
| Semiconductors | |||||||
| Achronix Semiconductor Corporation | Warrant | 6/26/2015 | Preferred Series D-2 | 750,000 | 99 | 811 | |
| Subtotal: Semiconductors (0.04%)* | 99 | 811 | |||||
| Software | |||||||
| Aria Systems, Inc. | Warrant | 5/22/2015 | Preferred Series G | 231,535 | 74 | — | |
| Automation Anywhere, Inc. | Warrant | 9/23/2022 | Common Stock | 254,778 | 448 | 430 | |
| Bitsight Technologies, Inc. | Warrant | 11/18/2020 | Common Stock | 29,691 | 284 | 666 | |
| Brain Corporation | Warrant | 10/4/2021 | Common Stock | 194,629 | 165 | 47 | (15) |
| CloudBolt Software, Inc. | Warrant | 9/30/2020 | Common Stock | 211,342 | 117 | 12 | |
| Cloudian, Inc. | Warrant | 11/6/2018 | Common Stock | 477,454 | 71 | 29 | |
| Cloudpay, Inc. | Warrant | 4/10/2018 | Preferred Series B | 6,763 | 54 | 844 | (5)(10) |
| Couchbase, Inc. | Warrant | 4/25/2019 | Common Stock | 105,350 | 462 | 1,225 | (4) |
| Cutover, Inc. | Warrant | 9/21/2022 | Common Stock | 102,898 | 26 | 62 | (5)(10)(12) |
| Dashlane, Inc. | Warrant | 3/11/2019 | Common Stock | 770,838 | 461 | 258 | |
| Delphix Corp. | Warrant | 10/8/2019 | Common Stock | 718,898 | 1,594 | 3,801 | |
| Demandbase, Inc. | Warrant | 8/2/2021 | Common Stock | 727,047 | 545 | 396 | |
| DNAnexus, Inc. | Warrant | 3/21/2014 | Preferred Series C | 909,091 | 97 | 47 | |
| Dragos, Inc. | Warrant | 6/28/2023 | Common Stock | 49,309 | 1,452 | 1,207 | |
| DroneDeploy, Inc. | Warrant | 6/30/2022 | Common Stock | 95,911 | 278 | 413 | |
| Eigen Technologies Ltd. | Warrant | 4/13/2022 | Common Stock | 522 | 8 | 4 | (5)(10) |
| Elation Health, Inc. | Warrant | 9/12/2022 | Common Stock | 362,837 | 583 | 188 | |
| First Insight, Inc. | Warrant | 5/10/2018 | Preferred Series B | 75,917 | 96 | 77 | |
| Fulfil Solutions, Inc. | Warrant | 7/29/2022 | Common Stock | 84,995 | 325 | 456 | |
| Kore.ai, Inc. | Warrant | 3/31/2023 | Preferred Series C | 64,293 | 208 | 243 | |
| Leapwork ApS | Warrant | 1/23/2023 | Common Stock | 39,948 | 16 | 35 | (5)(10)(12) |
| Lightbend, Inc. | Warrant | 2/14/2018 | Preferred Series D | 89,685 | 131 | 49 | |
| Mixpanel, Inc. | Warrant | 9/30/2020 | Common Stock | 82,362 | 252 | 306 | |
| Onna Technologies, Inc. | Warrant | 7/5/2023 | Common Stock | 172,867 | 60 | 39 | |
| Portfolio Company · Type ofInvestment · Acquisition Date(4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Poplicus, Inc. | Warrant | 5/28/2014 | Common Stock | 132,168 | $— | $— | ||||
| Reltio, Inc. | Warrant | 6/30/2020 | Common Stock | 69,120 | 215 | 447 | ||||
| Simon Data, Inc. | Warrant | 3/22/2023 | Common Stock | 77,934 | 96 | 76 | (12) | |||
| SingleStore, Inc. | Warrant | 4/28/2020 | Preferred Series D | 312,596 | 103 | 386 | ||||
| Sisense Ltd. | Warrant | 6/8/2023 | Ordinary Shares | 321,956 | 174 | 128 | (5)(10) | |||
| Suzy, Inc. | Warrant | 8/24/2023 | Common Stock | 292,936 | 367 | 354 | (15) | |||
| The Faction Group LLC | Warrant | 11/3/2014 | Preferred Series AA | 8,076 | 234 | 904 | ||||
| Tipalti Solutions Ltd. | Warrant | 3/22/2023 | Ordinary Shares | 254,877 | 174 | 234 | (5)(10) | |||
| VideoAmp, Inc. | Warrant | 1/21/2022 | Common Stock | 152,048 | 1,275 | 186 | (15) | |||
| Subtotal: Software (0.75%)* | 10,445 | 13,549 | ||||||||
| Surgical Devices | ||||||||||
| TransMedics Group, Inc. | Warrant | 9/11/2015 | Common Stock | 14,440 | 39 | 676 | (4) | |||
| Subtotal: Surgical Devices (0.04%)* | 39 | 676 | ||||||||
| Sustainable and Renewable Technology | ||||||||||
| Ampion, PBC | Warrant | 4/15/2022 | Common Stock | 18,472 | 52 | 36 | ||||
| Halio, Inc. | Warrant | 4/22/2014 | Preferred Series A | 325,000 | 155 | 36 | ||||
| Warrant | 4/7/2015 | Preferred Series B | 131,883 | 63 | 11 | |||||
| Total Halio, Inc. | 456,883 | 218 | 47 | |||||||
| Polyera Corporation | Warrant | 3/24/2015 | Preferred Series C | 150,036 | 269 | — | ||||
| Subtotal: Sustainable and Renewable Technology (0.00%)* | 539 | 83 | ||||||||
| Total: Warrant Investments (1.88%)* | $28,954 | $33,969 | ||||||||
| Total Investments in Securities (179.92%)* | $3,242,550 | $3,243,438 | ||||||||
| Investment Funds & Vehicles Investments | ||||||||||
| Drug Discovery & Development | ||||||||||
| Forbion Growth Opportunities Fund I C.V. | Investment Funds & Vehicles | 11/16/2020 | $3,783 | $3,619 | (5)(10)(17) | |||||
| Forbion Growth Opportunities Fund II C.V. | Investment Funds & Vehicles | 6/23/2022 | 319 | 611 | (5)(10)(17) | |||||
| Subtotal: Drug Discovery & Development (0.23%)* | $4,102 | 4,230 | ||||||||
| Software | ||||||||||
| Liberty Zim Co-Invest L.P. | Investment Funds & Vehicles | 7/21/2022 | 381 | 378 | (5)(10) | |||||
| Subtotal: Software (0.02%)* | 381 | 378 | ||||||||
| Total: Investment Funds & Vehicles Investments (0.26%)* | $4,483 | $4,608 | ||||||||
| Total Investments (180.18%)* | $3,247,033 | $3,248,046 | ||||||||
| Cash & Cash Equivalents | ||||||||||
| GS Financial Square Government Fund | Cash & Cash Equivalents | FGTXX/38141W273 | $56,000 | $56,000 | ||||||
| Total: Investments in Cash & Cash Equivalents (3.11%)* | $56,000 | $56,000 | ||||||||
| Total: Investments after Cash & Cash Equivalents (183.28%)* | $3,303,033 | $3,304,046 | ||||||||
| Foreign Currency Forward Contracts | ||||||||
|---|---|---|---|---|---|---|---|---|
| Foreign Currency · Settlement Date · Counterparty · Amount · Transaction · US $ Value at Settlement Date · Value | ||||||||
| Great British Pound (GBP) | 6/3/2024 | Goldman Sachs Bank USA | £19,288 | Sold | $23,810 | $(766) | ||
| Total Foreign Currency Forward ((0.04))* | $23,810 | $(766) | ||||||
*Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
(1)Interest rate PRIME represents 8.50% as of December 31, 2023. 1-month SOFR, 3-month SOFR, and 6-month SOFR represent 5.34%,5.36%, and 5.35%, respectively, as of December 31, 2023.
(2)Gross unrealized appreciation, gross unrealized depreciation, and net unrealized appreciation for federal income tax purposes totaled $118.3 million, $115.9 million, and $2.4 million, respectively. The tax cost of investments is $3.2 billion.
(3)Preferred and common stock, warrants, and equity interests are generally non-income producing.
(4)Except for warrants in 24 publicly traded companies and common stock in 36 publicly traded companies, all investments are restricted as of December 31, 2023 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”).
(5)Non-U.S. company or the company’s principal place of business is outside the United States.
(6)[Reserved]
(7)Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
(8)Debt is on non-accrual status as of December 31, 2023, and is therefore considered non-income producing.
(9)Denotes that all or a portion of the debt investment is convertible debt.
(10)Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
(11)Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
(12)Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
(13)Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
(14)Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
(15)Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
(16)Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2023.
(17)Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2023 (Refer to “Note 11 — Commitments and Contingencies”).
(18)Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
(19)Denotes second lien senior secured debt.
(20)Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC.
(21)Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2023, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.4 million.
(22)Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $12.0 million and $9.4 million, respectively.
(23)Hercules Adviser LLC is owned by Hercules Capital Management LLC and presented with Hercules Partner Holdings, LLC which are both wholly owned by the Company. Please refer to “Note 1” for additional disclosure.
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Investments | |||||||||||
| Biotechnology Tools | |||||||||||
| Alamar Biosciences, Inc. | Senior Secured | June 2026 | Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee | $5,000 | $4,951 | $4,951 | (17) | ||||
| PathAI, Inc. | Senior Secured | January 2027 | Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee | $28,000 | 27,388 | 27,388 | (17) | ||||
| Subtotal: Biotechnology Tools (2.31%)* | 32,339 | 32,339 | |||||||||
| Communications & Networking | |||||||||||
| Aryaka Networks, Inc. | Senior Secured | July 2026 | Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee | $5,023 | 4,969 | 5,053 | (14)(17)(19) | ||||
| Cytracom Holdings LLC | Senior Secured | February 2025 | 3-month LIBOR + 9.31% or Floor rate of 10.31% | $8,910 | 8,768 | 8,748 | (11)(17)(18) | ||||
| Rocket Lab Global Services, LLC | Senior Secured | June 2024 | PRIME + 4.90% or Floor rate of 8.15%, PIK Interest 1.25%, 3.25% Exit Fee | $84,581 | 85,430 | 87,933 | (11)(12)(13)(14)(16) | ||||
| Subtotal: Communications & Networking (7.26%)* | 99,167 | 101,734 | |||||||||
| Consumer & Business Services | |||||||||||
| AppDirect, Inc. | Senior Secured | April 2026 | Prime + 5.50%, Floor rate 8.75%, 8.29% Exit Fee | $40,790 | 41,856 | 42,426 | (12)(17) | ||||
| Carwow LTD | Senior Secured | December 2024 | Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee | £18,890 | 26,024 | 22,971 | (5)(10)(14) | ||||
| Houzz, Inc. | Convertible Debt | May 2028 | PIK Interest 5.50% | $21,853 | 21,853 | 20,356 | (9)(14) | ||||
| Jobandtalent USA, Inc. | Senior Secured | February 2025 | 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee | $14,000 | 13,853 | 13,904 | (5)(10) | ||||
| Provi | Senior Secured | December 2026 | Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee | $15,000 | 14,739 | 14,739 | (15) | ||||
| Rhino Labs, Inc. | Senior Secured | March 2024 | Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%% | $16,500 | 16,328 | 16,496 | (14)(15) | ||||
| RVShare, LLC | Senior Secured | December 2026 | 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% | $27,730 | 27,265 | 27,256 | (13)(14)(15)(17) | ||||
| SeatGeek, Inc. | Senior Secured | June 2023 | Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50% | $60,915 | 60,721 | 60,721 | (12)(13)(14)(16) | ||||
| Senior Secured | May 2026 | Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50% | $25,071 | 24,912 | 25,823 | (11)(14)(16) | |||||
| Total SeatGeek, Inc. | $85,986 | 85,633 | 86,544 | ||||||||
| Skyword, Inc. | Senior Secured | November 2026 | Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee | $9,007 | 8,918 | 8,870 | (13)(14) | ||||
| Tectura Corporation | Senior Secured | July 2024 | PIK Interest 5.00% | $10,680 | 240 | — | (7)(8)(14) | ||||
| Senior Secured | July 2024 | FIXED 8.25% | $8,250 | 8,250 | 8,042 | (7)(8)(14) | |||||
| Senior Secured | July 2024 | PIK Interest 5.00% | $13,023 | 13,023 | — | (7)(8)(14) | |||||
| Total Tectura Corporation | $31,953 | 21,513 | 8,042 | ||||||||
| Thumbtack, Inc. | Senior Secured | April 2026 | Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee | $10,103 | 10,050 | 10,167 | (12)(14)(17) | ||||
| Udacity, Inc. | Senior Secured | September 2024 | Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee | $51,937 | 52,265 | 52,976 | (12)(14) | ||||
| Veem, Inc. | Senior Secured | March 2025 | Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee | $5,043 | 5,000 | 5,042 | (13)(14) | ||||
| Senior Secured | March 2025 | Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee | $5,033 | 4,988 | 5,124 | (14) | |||||
| Total Veem, Inc. | $10,076 | 9,988 | 10,166 | ||||||||
| Worldremit Group Limited | Senior Secured | February 2025 | 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee | $94,500 | 94,418 | 93,837 | (5)(10)(11)(12)(16)(19) | ||||
| Subtotal: Consumer & Business Services (30.59%)* | 444,703 | 428,750 | |||||||||
| Diversified Financial Services | |||||||||||
| Gibraltar Business Capital, LLC | Unsecured | September 2026 | FIXED 14.50% | $15,000 | 14,715 | 12,802 | (7) | ||||
| Unsecured | September 2026 | FIXED 11.50% | $10,000 | 9,852 | 8,898 | (7) | |||||
| Total Gibraltar Business Capital, LLC | $25,000 | 24,567 | 21,700 | ||||||||
| Portfolio Company | Type of Investment | Maturity Date | Interest Rate and Floor (1) | PrincipalAmount | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Hercules Adviser LLC | Unsecured | June 2025 | FIXED 5.00% | $12,000 | $12,000 | $12,000 | (7) |
| Subtotal: Diversified Financial Services (2.40%)* | 36,567 | 33,700 | |||||
| Drug Discovery & Development | |||||||
| Akero Therapeutics, Inc. | Senior Secured | January 2027 | Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee | $5,000 | 4,986 | 5,039 | (10)(13)(17) |
| Aldeyra Therapeutics, Inc. | Senior Secured | October 2024 | Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee | $15,000 | 15,879 | 15,974 | (11) |
| Alladapt Immunotherapeutics Inc. | Senior Secured | September 2026 | Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee | $15,000 | 14,920 | 14,920 | (13)(17) |
| AmplifyBio, LLC | Senior Secured | January 2027 | Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee | $24,000 | 23,663 | 23,663 | (15) |
| ATAI Life Sciences N.V. | Senior Secured | August 2026 | Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee | $10,500 | 10,513 | 10,513 | (5)(10) |
| Aveo Pharmaceuticals, Inc. | Senior Secured | September 2024 | Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00% , 6.95% Exit Fee | $40,000 | 41,644 | 43,183 | (11)(15) |
| Axsome Therapeutics, Inc. | Senior Secured | October 2026 | Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee | $81,725 | 81,631 | 78,074 | (10)(11)(12)(16)(17) |
| Bicycle Therapeutics PLC | Senior Secured | July 2025 | Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee | $11,500 | 11,757 | 11,435 | (5)(10)(11)(12) |
| BiomX, INC | Senior Secured | September 2025 | Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee | $9,000 | 9,174 | 9,052 | (5)(10)(11) |
| BridgeBio Pharma, Inc. | Senior Secured | November 2026 | FIXED 9.00%, 2.00% Exit Fee | $37,312 | 37,039 | 33,344 | (12)(13)(14) |
| Cellarity, Inc. | Senior Secured | June 2026 | Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee | $30,000 | 29,841 | 30,097 | (13)(15) |
| Century Therapeutics, Inc. | Senior Secured | April 2024 | Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee | $10,000 | 10,235 | 10,292 | (11) |
| Codiak Biosciences, Inc. | Senior Secured | October 2025 | Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee | $25,000 | 25,759 | 25,177 | (11) |
| Corium, Inc. | Senior Secured | September 2026 | Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee | $132,675 | 133,557 | 135,619 | (13)(16) |
| Eloxx Pharmaceuticals, Inc. | Senior Secured | April 2025 | Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee | $12,500 | 12,753 | 12,535 | (15) |
| enGene, Inc. | Senior Secured | July 2025 | Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee | $11,000 | 11,072 | 11,067 | (5)(10)(12)(13) |
| Finch Therapeutics Group, Inc. | Senior Secured | November 2026 | Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee | $15,000 | 15,012 | 13,940 | |
| G1 Therapeutics, Inc. | Senior Secured | November 2026 | Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee | $58,125 | 58,674 | 58,407 | (11)(12)(15)(17) |
| Geron Corporation | Senior Secured | October 2024 | Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee | $18,500 | 19,109 | 19,174 | (10)(12)(13) |
| Gritstone Bio, Inc. | Senior Secured | July 2027 | Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee | $15,113 | 15,109 | 15,109 | (14)(17) |
| Hibercell, Inc. | Senior Secured | May 2025 | Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee | $17,000 | 17,313 | 17,265 | (13)(15) |
| HilleVax, Inc. | Senior Secured | May 2027 | Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee | $12,072 | 12,043 | 11,333 | (14)(15)(17) |
| Iveric Bio, Inc. | Senior Secured | August 2027 | Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee | $49,500 | 49,090 | 49,090 | (10)(12) |
| Kura Oncology, Inc. | Senior Secured | November 2027 | Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee | $5,500 | 5,448 | 5,448 | (10)(15)(17) |
| Locus Biosciences, Inc. | Senior Secured | July 2025 | Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee | $8,000 | 8,120 | 8,085 | (15) |
| Madrigal Pharmaceutical, Inc. | Senior Secured | May 2026 | Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee | $34,000 | 33,945 | 33,987 | (10)(17) |
| Nabriva Therapeutics | Senior Secured | June 2023 | Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee | $2,079 | 2,734 | 2,804 | (5)(10)(13) |
| Phathom Pharmaceuticals, Inc. | Senior Secured | October 2026 | Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee | $94,737 | 95,032 | 93,916 | (10)(12)(14)(15)(16)(17)(22) |
| Provention Bio, Inc. | Senior Secured | September 2027 | Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee | $25,000 | 24,670 | 24,670 | (17) |
| Redshift Bioanalytics, Inc. | Senior Secured | January 2026 | Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee | $5,000 | 4,957 | 4,946 | (15) |
| Replimune Group, Inc. | Senior Secured | October 2027 | Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee | $20,754 | 20,656 | 20,656 | (10)(14)(17) |
| Scynexis, Inc. | Senior Secured | March 2025 | Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee | $18,667 | 18,675 | 18,698 | (12)(13) |
| Seres Therapeutics, Inc. | Senior Secured | October 2024 | Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee | $37,500 | 38,638 | 38,816 | (12)(13) |
| Tarsus Pharmaceuticals, Inc. | Senior Secured | February 2027 | Prime + 5.20%, Floor rate 8.45% , 4.75% Exit Fee | $8,250 | 8,274 | 8,423 | (10)(13)(17) |
| Portfolio Company · Type of Investment · Maturity Date · Interest Rate and Floor (1) · PrincipalAmount · Cost (2) · Value · Footnotes | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| TG Therapeutics, Inc. | Senior Secured | January 2026 | Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee | $47,983 | $47,889 | $48,649 | (10)(11)(12)(14) | ||
| uniQure B.V. | Senior Secured | December 2025 | Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee | $70,000 | 72,329 | 73,019 | (5)(10)(11)(12)(16) | ||
| Unity Biotechnology, Inc. | Senior Secured | August 2024 | Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee | $20,000 | 21,079 | 20,967 | (13) | ||
| Valo Health, LLC | Senior Secured | May 2024 | Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee | $8,146 | 8,416 | 8,410 | (11)(13) | ||
| Viridian Therapeutics, Inc. | Senior Secured | October 2026 | Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee | $2,000 | 2,012 | 1,934 | (10)(13)(17) | ||
| X4 Pharmaceuticals, Inc. | Senior Secured | July 2024 | Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee | $32,500 | 33,705 | 33,700 | (11)(12)(13) | ||
| Subtotal: Drug Discovery & Development (78.59%)* | 1,107,352 | 1,101,430 | |||||||
| Electronics & Computer Hardware | |||||||||
| Locus Robotics Corp. | Senior Secured | June 2026 | Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee | $18,281 | 18,171 | 18,723 | (19) | ||
| Subtotal: Electronics & Computer Hardware (1.34%)* | 18,171 | 18,723 | |||||||
| Healthcare Services, Other | |||||||||
| Better Therapeutics, Inc. | Senior Secured | August 2025 | Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee | $12,000 | 12,162 | 12,053 | (15) | ||
| Blue Sprig Pediatrics, Inc. | Senior Secured | November 2026 | 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45% | $51,480 | 50,813 | 49,732 | (11)(13)(14) | ||
| Carbon Health Technologies, Inc. | Senior Secured | March 2025 | Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee | $46,125 | 46,552 | 46,548 | (11)(13)(19) | ||
| Equality Health, LLC | Senior Secured | February 2026 | Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% | $53,587 | 53,164 | 53,871 | (12)(14) | ||
| Oak Street Health, Inc. | Senior Secured | October 2027 | Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee | $33,808 | 33,651 | 33,651 | (10)(14)(17) | ||
| Subtotal: Healthcare Services, Other (13.98%)* | 196,342 | 195,855 | |||||||
| Information Services | |||||||||
| Capella Space Corp. | Senior Secured | November 2025 | Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee | $20,250 | 20,506 | 20,574 | (14)(15)(19) | ||
| Signal Media Limited | Senior Secured | June 2025 | Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee | $750 | 742 | 738 | (5)(10)(17) | ||
| Yipit, LLC | Senior Secured | September 2026 | 1-month SOFR + 9.08%, Floor rate 10.08% | $31,875 | 31,371 | 30,763 | (17)(18) | ||
| Subtotal: Information Services (3.72%)* | 52,619 | 52,075 | |||||||
| Manufacturing Technology | |||||||||
| Bright Machines, Inc. | Senior Secured | April 2025 | Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee | $11,050 | 10,832 | 10,832 | (13) | ||
| MacroFab, Inc. | Senior Secured | March 2026 | Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee | $17,137 | 16,766 | 16,917 | (14)(17) | ||
| Ouster, Inc. | Senior Secured | May 2026 | Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee | $14,000 | 13,970 | 14,204 | (10)(13) | ||
| Subtotal: Manufacturing Technology (2.99%)* | 41,568 | 41,953 | |||||||
| Semiconductors | |||||||||
| Fungible, Inc. | Senior Secured | December 2024 | Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee | $20,000 | 19,639 | 21,192 | (15)(19) | ||
| Subtotal: Semiconductors (1.51%)* | 19,639 | 21,192 | |||||||
| Software | |||||||||
| 3GTMS, LLC | Senior Secured | February 2025 | 3-month LIBOR + 9.28%, Floor rate 10.28% | $10,426 | 10,291 | 10,317 | (11)(18) | ||
| Senior Secured | February 2025 | 3-month LIBOR + 6.57%, Floor rate 7.57% | $2,750 | 2,744 | 2,681 | (18) | |||
| Total 3GTMS, LLC | $13,176 | 13,035 | 12,998 | ||||||
| Agilence, Inc. | Senior Secured | October 2026 | 1-month BSBY + 9.00%, Floor rate 10.00% | $9,306 | 9,088 | 8,977 | (12)(17)(18) | ||
| Alchemer LLC | Senior Secured | May 2028 | 1-month SOFR + 7.89% Floor rate 8.89% | $20,463 | 19,999 | 20,123 | (17)(18) | ||
| Annex Cloud | Senior Secured | February 2027 | 1-month BSBY + 8.99%, Floor rate 10.00% | $8,500 | 8,292 | 8,176 | (13)(17) | ||
| Automation Anywhere, Inc. | Senior Secured | September 2027 | Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee | $19,600 | 19,059 | 19,059 | (11)(17)(19) | ||
| Portfolio Company | Type of Investment | Maturity Date | Interest Rate and Floor (1) | PrincipalAmount | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Babel Street | Senior Secured | December 2027 | 3-month SOFR + 7.89%, Floor rate 8.89% | $45,000 | $43,801 | $43,801 | (15)(17)(18) |
| Brain Corporation | Senior Secured | April 2025 | Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee | $20,166 | 20,242 | 20,138 | (13)(14)(15)(17) |
| Campaign Monitor Limited | Senior Secured | November 2025 | 6-month SOFR + 8.90%, Floor rate 9.90% | $33,000 | 32,578 | 33,000 | (13)(19) |
| Catchpoint Systems, Inc. | Senior Secured | June 2026 | 3-month SOFR + 8.86%, Floor rate 9.76% | $10,175 | 9,980 | 9,996 | (18) |
| Ceros, Inc. | Senior Secured | September 2026 | 6-month LIBOR + 9.67%, Floor rate 10.67% | $21,445 | 21,003 | 21,050 | (17)(18) |
| CloudBolt Software, Inc. | Senior Secured | October 2024 | Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee | $10,000 | 10,069 | 10,498 | (11)(19) |
| Constructor.io Corporation | Senior Secured | July 2027 | 1-month SOFR + 8.44%, Floor rate 9.44% | $4,688 | 4,573 | 4,573 | (17)(18) |
| Convoy, Inc. | Senior Secured | March 2026 | Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee | $73,987 | 73,060 | 73,498 | (14)(16)(19) |
| Copper CRM, Inc | Senior Secured | March 2025 | Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee | $10,144 | 10,150 | 9,820 | (11)(14) |
| Cutover, Inc. | Senior Secured | October 2025 | Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee | $5,000 | 4,949 | 4,949 | (5)(10)(12)(17) |
| Cybermaxx Intermediate Holdings, Inc. | Senior Secured | August 2026 | 6-month SOFR + 9.53%, Floor rate 10.28% | $10,528 | 10,298 | 10,114 | (13)(17) |
| Dashlane, Inc. | Senior Secured | July 2025 | Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee | $31,930 | 32,346 | 32,012 | (11)(13)(14)(17)(19) |
| Demandbase, Inc. | Senior Secured | August 2025 | Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee | $28,503 | 28,442 | 28,664 | (13)(14)(17)(19) |
| Dispatch Technologies, Inc. | Senior Secured | April 2028 | 3-month SOFR + 8.01%, Floor rate 8.76% | $7,500 | 7,295 | 7,339 | (17)(18) |
| Eigen Technologies Ltd. | Senior Secured | April 2025 | Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee | $3,750 | 3,744 | 3,746 | (5)(10) |
| Elation Health, Inc. | Senior Secured | March 2026 | Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee | $5,021 | 4,839 | 4,839 | (14)(17)(19) |
| Enmark Systems, Inc. | Senior Secured | September 2026 | 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16% | $8,223 | 8,054 | 8,043 | (11)(14)(17)(18) |
| Esentire, Inc. | Senior Secured | May 2024 | 3-month LIBOR + 9.96%, Floor rate 10.96% | $8,436 | 8,361 | 8,376 | (5)(10)(11)(18) |
| Esme Learning Solutions, Inc. | Senior Secured | February 2025 | Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee | $4,892 | 4,737 | 1,671 | (8)(14) |
| Fortified Health Security | Senior Secured | December 2027 | 6-month SOFR + 7.79%, Floor rate 8.54% | $7,000 | 6,824 | 6,824 | (17)(18) |
| Flight Schedule Pro, LLC | Senior Secured | October 2027 | 1-month SOFR + 7.79%, Floor rate 8.70% | $5,948 | 5,771 | 5,771 | (17)(18) |
| Ikon Science Limited | Senior Secured | October 2024 | 3-month Eurodollar + 9.00%, Floor rate 10.00% | $6,563 | 6,422 | 6,484 | (5)(10)(17)(18) |
| Imperva, Inc. | Senior Secured | January 2027 | 3-month LIBOR + 7.75%, Floor rate 8.75% | $20,000 | 19,875 | 20,200 | (19) |
| Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured | July 2023 | 3-month SOFR + 10.14%, Floor rate 11.14% | $10,681 | 10,593 | 10,593 | (18) |
| Khoros (p.k.a Lithium Technologies) | Senior Secured | January 2024 | 3-month SOFR + 8.00%, Floor rate 9.00% | $56,208 | 56,062 | 55,520 | (17) |
| LogicSource | Senior Secured | July 2027 | 3-month SOFR + 8.93%, Floor rate 9.93% | $13,300 | 13,028 | 13,028 | (17) |
| Logicworks | Senior Secured | January 2024 | Prime + 7.50%, Floor rate 10.75% | $14,500 | 14,398 | 14,473 | (12) |
| Mobile Solutions Services | Senior Secured | December 2025 | 3-month LIBOR + 9.06%, Floor rate 10.06% | $17,915 | 17,556 | 17,474 | (17)(18) |
| Nextroll, Inc. | Senior Secured | July 2023 | Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee | $22,211 | 22,284 | 22,284 | (12)(14) |
| Nuvolo Technologies Corporation | Senior Secured | July 2025 | Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee | $22,500 | 22,508 | 22,817 | (12)(13)(17)(19) |
| Omeda Holdings, LLC | Senior Secured | July 2027 | 3-month SOFR + 8.05%, Floor rate 9.05% | $7,500 | 7,261 | 7,261 | (17)(18) |
| Riviera Partners LLC | Senior Secured | April 2027 | 6-month SOFR + 7.53%, Floor rate 8.53% | $26,184 | 25,622 | 25,487 | (17)(18) |
| Salary.com, LLC | Senior Secured | September 2027 | 6-month SOFR + 8.00%, Floor rate 9.00% | $18,000 | 17,654 | 17,654 | (18) |
| ShadowDragon, LLC | Senior Secured | December 2026 | 3-month LIBOR + 9.00%, Floor rate 10.00% | $5,985 | 5,841 | 5,830 | (17)(18) |
| Tact.ai Technologies, Inc. | Senior Secured | February 2024 | Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee | $4,250 | 4,481 | 4,446 | (14) |
| ThreatConnect, Inc. | Senior Secured | May 2026 | 6-month LIBOR + 9.00%, Floor rate 10.00% | $11,032 | 10,778 | 10,793 | (17)(18) |
| VideoAmp, Inc. | Senior Secured | February 2025 | Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee | $63,187 | 62,640 | 63,429 | (14)(15)(19) |
| Zappi, Inc. | Senior Secured | December 2027 | 3-month SOFR + 8.03%, Floor rate 9.03% | $9,000 | 8,779 | 8,779 | (5)(10)(17)(18) |
| Portfolio Company | Type of Investment | Maturity Date | Interest Rate and Floor (1) | PrincipalAmount | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Zimperium, Inc. | Senior Secured | May 2027 | 3-month SOFR + 8.31%, Floor rate 9.31% | $16,313 | $16,000 | $16,072 | (17)(18) |
| Subtotal: Software (54.28%)* | 762,371 | 760,679 | |||||
| Sustainable and Renewable Technology | |||||||
| Ampion, PBC | Senior Secured | May 2025 | Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee | $4,037 | 3,985 | 4,008 | (13)(14) |
| Pineapple Energy LLC | Senior Secured | December 2024 | PIK Interest 10.00% | $3,237 | 3,237 | 3,006 | (14) |
| Subtotal: Sustainable and Renewable Technology (0.50%)* | 7,222 | 7,014 | |||||
| Total: Debt Investments (199.47%)* | $2,818,060 | $2,795,444 | |||||
| Portfolio Company · Type ofInvestment · Acquisition Date (4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Investments | ||||||||||
| Consumer & Business Products | ||||||||||
| Grove Collaborative, Inc. | Equity | 4/30/2021 | Common Stock | 61,300 | $433 | $24 | (4) | |||
| Savage X Holding, LLC | Equity | 4/30/2010 | Class A Units | 42,137 | 13 | 226 | ||||
| TechStyle, Inc. | Equity | 4/30/2010 | Common Stock | 42,989 | 128 | 132 | ||||
| TFG Holding, Inc. | Equity | 4/30/2010 | Common Stock | 42,989 | 89 | 116 | ||||
| Subtotal: Consumer & Business Products (0.04%)* | 663 | 498 | ||||||||
| Consumer & Business Services | ||||||||||
| Carwow LTD | Equity | 12/15/2021 | Preferred Series D-4 | 199,742 | 1,151 | 257 | (5)(10) | |||
| DoorDash, Inc. | Equity | 12/20/2018 | Common Stock | 81,996 | 945 | 4,003 | (4) | |||
| Lyft, Inc. | Equity | 12/26/2018 | Common Stock | 100,738 | 5,263 | 1,110 | (4) | |||
| Nerdy Inc. | Equity | 9/17/2021 | Common Stock | 100,000 | 1,000 | 225 | (4) | |||
| OfferUp, Inc. | Equity | 10/25/2016 | Preferred Series A | 286,080 | 1,663 | 372 | ||||
| Equity | 10/25/2016 | Preferred Series A-1 | 108,710 | 632 | 141 | |||||
| Total OfferUp, Inc. | 394,790 | 2,295 | 513 | |||||||
| Oportun | Equity | 6/28/2013 | Common Stock | 48,365 | 577 | 266 | (4) | |||
| Reischling Press, Inc. | Equity | 7/31/2020 | Common Stock | 3,095 | 39 | — | ||||
| Rhino Labs, Inc. | Equity | 1/24/2022 | Preferred Series B-2 | 7,063 | 1,000 | 805 | ||||
| Tectura Corporation | Equity | 5/23/2018 | Common Stock | 414,994,863 | 900 | — | (7) | |||
| Equity | 6/6/2016 | Preferred Series BB | 1,000,000 | — | — | (7) | ||||
| Total Tectura Corporation | 415,994,863 | 900 | — | |||||||
| Uber Technologies, Inc. | Equity | 12/1/2020 | Common Stock | 32,991 | 318 | 816 | (4) | |||
| Subtotal: Consumer & Business Products (0.57%)* | 13,488 | 7,995 | ||||||||
| Diversified Financial Services | ||||||||||
| Gibraltar Business Capital, LLC | Equity | 3/1/2018 | Common Stock | 830,000 | 1,884 | 1,107 | (7) | |||
| Equity | 3/1/2018 | Preferred Series A | 10,602,752 | 26,122 | 14,137 | (7) | ||||
| Total Gibraltar Business Capital, LLC | 11,432,752 | 28,006 | 15,244 | |||||||
| Hercules Adviser LLC | Equity | 3/26/2021 | Member Units | 1 | 35 | 19,153 | (7) | |||
| Portfolio Company · Type ofInvestment · Acquisition Date (4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Newfront Insurance Holdings, Inc. | Equity | 9/30/2021 | Preferred Series D-2 | 210,282 | $403 | $472 | ||||
| Subtotal: Diversified Financial Services (2.49%)* | 28,444 | 34,869 | ||||||||
| Drug Delivery | ||||||||||
| AcelRx Pharmaceuticals, Inc. | Equity | 12/10/2018 | Common Stock | 8,836 | 1,329 | 20 | (4) | |||
| Aytu BioScience, Inc. | Equity | 3/28/2014 | Common Stock | 13,600 | 1,500 | 3 | (4) | |||
| BioQ Pharma Incorporated | Equity | 12/8/2015 | Preferred Series D | 165,000 | 500 | 33 | ||||
| PDS Biotechnology Corporation | Equity | 4/6/2015 | Common Stock | 2,498 | 309 | 33 | (4) | |||
| Subtotal: Drug Delivery (0.01%)* | 3,638 | 89 | ||||||||
| Drug Discovery & Development | ||||||||||
| Akero Therapeutics, Inc. | Equity | 9/19/2022 | Common Stock | 38,461 | 1,000 | 2,108 | (4)(10) | |||
| Albireo Pharma, Inc. | Equity | 9/14/2020 | Common Stock | 25,000 | 1,000 | 540 | (4)(10) | |||
| Applied Molecular Transport | Equity | 4/6/2021 | Common Stock | 1,000 | 42 | — | (4)(10) | |||
| Avalo Therapeutics, Inc. | Equity | 8/19/2014 | Common Stock | 9,924 | 1,000 | 50 | (4) | |||
| Aveo Pharmaceuticals, Inc. | Equity | 7/31/2011 | Common Stock | 190,179 | 1,715 | 2,843 | (4) | |||
| Axsome Therapeutics, Inc. | Equity | 5/9/2022 | Common Stock | 127,021 | 4,165 | 9,797 | (4)(10)(16) | |||
| Bicycle Therapeutics PLC | Equity | 10/5/2020 | Common Stock | 98,100 | 1,871 | 2,904 | (4)(5)(10) | |||
| BridgeBio Pharma, Inc. | Equity | 6/21/2018 | Common Stock | 231,329 | 2,255 | 1,763 | (4) | |||
| Concert Pharmaceuticals, Inc. | Equity | 2/13/2019 | Common Stock | 70,796 | 1,367 | 413 | (4)(10) | |||
| Dare Biosciences, Inc. | Equity | 1/8/2015 | Common Stock | 13,550 | 1,000 | 11 | (4) | |||
| Dynavax Technologies | Equity | 7/22/2015 | Common Stock | 20,000 | 550 | 213 | (4)(10) | |||
| Gritstone Bio, Inc. | Equity | 10/26/2022 | Common Stock | 442,477 | 1,000 | 1,527 | (4) | |||
| Hibercell, Inc. | Equity | 5/7/2021 | Preferred Series B | 3,466,840 | 4,250 | 2,233 | (15) | |||
| HilleVax, Inc. | Equity | 5/3/2022 | Common Stock | 235,295 | 4,000 | 3,937 | (4) | |||
| Humanigen, Inc. | Equity | 3/31/2021 | Common Stock | 43,243 | 800 | 5 | (4)(10) | |||
| NorthSea Therapeutics | Equity | 12/15/2021 | Preferred Series C | 983 | 2,000 | 1,476 | (5)(10) | |||
| Paratek Pharmaceuticals, Inc. | Equity | 2/26/2007 | Common Stock | 76,362 | 2,744 | 143 | (4) | |||
| Rocket Pharmaceuticals, Ltd. | Equity | 8/22/2007 | Common Stock | 944 | 1,500 | 18 | (4) | |||
| Savara, Inc. | Equity | 8/11/2015 | Common Stock | 11,119 | 203 | 17 | (4) | |||
| Sio Gene Therapies, Inc. | Equity | 2/2/2017 | Common Stock | 16,228 | 1,269 | 7 | (4) | |||
| Tarsus Pharmaceuticals, Inc. | Equity | 5/5/2022 | Common Stock | 155,555 | 2,100 | 2,280 | (4)(10) | |||
| Tricida, Inc. | Equity | 2/28/2018 | Common Stock | 68,816 | 863 | 11 | (4) | |||
| uniQure B.V. | Equity | 1/31/2019 | Common Stock | 17,175 | 332 | 389 | (4)(5)(10)(16) | |||
| Valo Health, LLC | Equity | 12/11/2020 | Preferred Series B | 510,308 | 3,000 | 2,063 | ||||
| Equity | 10/31/2022 | Preferred Series C | 170,102 | 1,000 | 1,012 | |||||
| Total Valo Health, LLC | 680,410 | 4,000 | 3,075 | |||||||
| X4 Pharmaceuticals, Inc. | Equity | 11/26/2019 | Common Stock | 1,566,064 | 2,945 | 1,555 | (4) | |||
| Subtotal: Drug Discovery & Development (2.66%)* | 43,971 | 37,315 | ||||||||
| Portfolio Company | Type ofInvestment | Acquisition Date (4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| Electronics & Computer Hardware | |||||||
| Locus Robotics Corp. | Equity | 11/17/2022 | Preferred Series F | 15,116 | $650 | $606 | |
| Skydio, Inc. | Equity | 3/8/2022 | Preferred Series E | 248,900 | 1,500 | 915 | |
| Subtotal: Electronics & Computer Hardware (0.11%)* | 2,150 | 1,521 | |||||
| Healthcare Services, Other | |||||||
| 23andMe, Inc. | Equity | 3/11/2019 | Common Stock | 825,732 | 5,094 | 1,784 | (4) |
| Carbon Health Technologies, Inc. | Equity | 3/30/2021 | Preferred Series C | 217,880 | 1,687 | 1,110 | |
| Subtotal: Healthcare Services, Other (0.21%)* | 6,781 | 2,894 | |||||
| Information Services | |||||||
| Planet Labs, Inc. | Equity | 6/21/2019 | Common Stock | 547,880 | 615 | 2,383 | (4) |
| Yipit, LLC | Equity | 12/30/2021 | Preferred Series E | 41,021 | 3,825 | 3,375 | |
| Zeta Global Corp. | Equity | 11/20/2007 | Common Stock | 295,861 | — | 2,417 | (4) |
| Subtotal: Information Services (0.58%)* | 4,440 | 8,175 | |||||
| Medical Devices & Equipment | |||||||
| Coronado Aesthetics, LLC | Equity | 10/15/2021 | Common Units | 180,000 | — | 6 | (7) |
| 10/15/2021 | Preferred Series A-2 | 5,000,000 | 250 | 313 | (7) | ||
| Total Coronado Aesthetics, LLC | 5,180,000 | 250 | 319 | ||||
| Flowonix Medical Incorporated | Equity | 11/3/2014 | Preferred Series AA | 221,893 | 1,499 | — | |
| Gelesis, Inc. | Equity | 11/30/2009 | Common Stock | 1,490,700 | 871 | 433 | (4) |
| ViewRay, Inc. | Equity | 12/16/2013 | Common Stock | 36,457 | 333 | 163 | (4) |
| Subtotal: Medical Devices & Equipment (0.07%)* | 2,953 | 915 | |||||
| Semiconductors | |||||||
| Achronix Semiconductor Corporation | Equity | 7/1/2011 | Preferred Series C | 277,995 | 160 | 205 | |
| Subtotal: Semiconductors (0.01%)* | 160 | 205 | |||||
| Software | |||||||
| 3GTMS, LLC | Equity | 8/9/2021 | Common Stock | 1,000,000 | 1,000 | 793 | |
| Black Crow AI, Inc. affiliates | Equity | 3/24/2021 | Preferred Note | 3 | 3,000 | 3,000 | (21) |
| CapLinked, Inc. | Equity | 10/26/2012 | Preferred Series A-3 | 53,614 | 51 | 6 | |
| Contentful Global, Inc. | Equity | 12/22/2020 | Preferred Series C | 41,000 | 138 | 258 | (5)(10) |
| Equity | 11/20/2018 | Preferred Series D | 108,500 | 500 | 732 | (5)(10) | |
| Total Contentful Global, Inc. | 149,500 | 638 | 990 | ||||
| Docker, Inc. | Equity | 11/29/2018 | Common Stock | 20,000 | 4,284 | 503 | |
| Druva Holdings, Inc. | Equity | 10/22/2015 | Preferred Series 2 | 458,841 | 1,000 | 1,764 | |
| Equity | 8/24/2017 | Preferred Series 3 | 93,620 | 300 | 395 | ||
| Total Druva Holdings, Inc. | 552,461 | 1,300 | 2,159 | ||||
| HighRoads, Inc. | Equity | 1/18/2013 | Common Stock | 190 | 307 | — | |
| Lightbend, Inc. | Equity | 12/4/2020 | Common Stock | 38,461 | 265 | 24 | |
| Nextdoor.com, Inc. | Equity | 8/1/2018 | Common Stock | 1,019,255 | 4,854 | 2,100 | (4) |
| Palantir Technologies | Equity | 9/23/2020 | Common Stock | 1,418,337 | 8,670 | 9,106 | (4) |
| Portfolio Company | Type ofInvestment | Acquisition Date (4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| SingleStore, Inc. | Equity | 11/25/2020 | Preferred Series E | 580,983 | $2,000 | $1,940 | |
| Equity | 8/12/2021 | Preferred Series F | 52,956 | 280 | 221 | ||
| Total SingleStore, Inc. | 633,939 | 2,280 | 2,161 | ||||
| Sprinklr, Inc. | Equity | 3/22/2017 | Common Stock | 700,000 | 3,748 | 5,719 | (4) |
| Verana Health, Inc. | Equity | 7/8/2021 | Preferred Series E | 952,562 | 2,000 | 1,023 | |
| ZeroFox, Inc. | Equity | 5/7/2020 | Common Stock | 289,992 | 101 | 1,382 | (4)(20) |
| Subtotal: Software (2.07%)* | 32,498 | 28,966 | |||||
| Surgical Devices | |||||||
| Gynesonics, Inc. | Equity | 1/18/2007 | Preferred Series B | 219,298 | 250 | — | |
| Equity | 6/16/2010 | Preferred Series C | 656,538 | 282 | — | ||
| Equity | 2/8/2013 | Preferred Series D | 1,991,157 | 712 | — | ||
| Equity | 7/14/2015 | Preferred Series E | 2,786,367 | 429 | — | ||
| Equity | 12/18/2018 | Preferred Series F | 1,523,693 | 118 | — | ||
| Equity | 12/18/2018 | Preferred Series F-1 | 2,418,125 | 150 | — | ||
| Total Gynesonics, Inc. | 9,595,178 | 1,941 | — | ||||
| TransMedics Group, Inc. | 11/7/2012 | Common Stock | 50,000 | 538 | 2,546 | (4) | |
| Subtotal: Surgical Devices (0.18%)* | 2,479 | 2,546 | |||||
| Sustainable and Renewable Technology | |||||||
| Fulcrum Bioenergy, Inc. | Equity | 9/13/2012 | Preferred Series C-1 | 187,265 | 711 | 995 | |
| Impossible Foods, Inc. | Equity | 5/10/2019 | Preferred Series E-1 | 188,611 | 2,000 | 2,173 | |
| Modumetal, Inc. | Equity | 6/1/2015 | Common Stock | 1,035 | 500 | — | |
| NantEnergy, LLC | Equity | 8/31/2013 | Common Units | 59,665 | 102 | — | |
| Pineapple Energy LLC | Equity | 12/10/2020 | Common Stock | 304,486 | 3,153 | 634 | (4)(20) |
| Pivot Bio, Inc. | Equity | 6/28/2021 | Preferred Series D | 593,080 | 4,500 | 2,456 | |
| Proterra, Inc. | Equity | 5/28/2015 | Common Stock | 457,841 | 542 | 1,726 | (4) |
| Subtotal: Sustainable and Renewable Technology (0.57%)* | 11,508 | 7,984 | |||||
| Total: Equity Investments (9.56%)* | $153,173 | $133,972 | |||||
| Warrant Investments | |||||||
| Biotechnology Tools | |||||||
| Alamar Biosciences, Inc. | Warrant | 6/21/2022 | Preferred Series B | 15,399 | $24 | $23 | |
| PathAI, Inc. | Warrant | 12/23/2022 | Common Stock | 53,418 | 461 | 463 | |
| Subtotal: Biotechnology Tools (0.03%)* | 485 | 486 | |||||
| Communications & Networking | |||||||
| Aryaka Networks, Inc. | Warrant | 6/28/2022 | Common Stock | 229,611 | 123 | 99 | |
| Spring Mobile Solutions, Inc. | Warrant | 4/19/2013 | Common Stock | 2,834,375 | 418 | — | |
| Subtotal: Communications & Networking (0.01%)* | 541 | 99 | |||||
| Consumer & Business Products | |||||||
| Gadget Guard, LLC | Warrant | 6/3/2014 | Common Stock | 1,662,441 | 228 | — | |
| Savage X Holding, LLC | Warrant | 6/27/2014 | Class A Units | 206,185 | — | 1,103 | |
| Portfolio Company | Type ofInvestment | Acquisition Date (4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| TechStyle, Inc. | Warrant | 7/16/2013 | Preferred Series B | 206,185 | $1,101 | $745 | |
| TFG Holding, Inc. | Warrant | 6/27/2014 | Common Stock | 206,185 | — | — | |
| The Neat Company | Warrant | 8/13/2014 | Common Stock | 54,054 | 365 | — | |
| Whoop, Inc. | Warrant | 6/27/2018 | Preferred Series C | 686,270 | 18 | 475 | |
| Subtotal: Consumer & Business Products (0.17%)* | 1,712 | 2,323 | |||||
| Consumer & Business Services | |||||||
| Carwow LTD | Warrant | 12/14/2021 | Common Stock | 174,163 | 164 | 34 | (5)(10) |
| Houzz, Inc. | Warrant | 10/29/2019 | Common Stock | 529,661 | 20 | — | |
| Landing Holdings Inc. | Warrant | 3/12/2021 | Common Stock | 11,806 | 116 | 127 | (15) |
| Lendio, Inc. | Warrant | 3/29/2019 | Preferred Series D | 127,032 | 39 | 19 | |
| Provi | Warrant | 12/22/2022 | Common Stock | 117,042 | 166 | 155 | (15) |
| Rhino Labs, Inc. | Warrant | 3/12/2021 | Common Stock | 13,106 | 470 | 308 | (15) |
| RumbleON, Inc. | Warrant | 4/30/2018 | Common Stock | 5,139 | 88 | — | (4) |
| SeatGeek, Inc. | Warrant | 6/12/2019 | Common Stock | 1,379,761 | 842 | 1,332 | (12)(16) |
| Skyword, Inc. | Warrant | 11/14/2022 | Common Stock | 1,607,143 | 57 | 43 | |
| Warrant | 8/23/2019 | Preferred Series B | 444,444 | 83 | — | ||
| Total Skyword, Inc. | 2,051,587 | 140 | 43 | ||||
| Snagajob.com, Inc. | Warrant | 4/20/2020 | Common Stock | 600,000 | 16 | 43 | |
| Warrant | 6/30/2016 | Preferred Series A | 1,800,000 | 782 | 50 | ||
| Warrant | 8/1/2018 | Preferred Series B | 1,211,537 | 62 | 25 | ||
| Total Snagajob.com, Inc. | 3,611,537 | 860 | 118 | ||||
| Thumbtack, Inc. | Warrant | 5/1/2018 | Common Stock | 267,225 | 844 | 280 | (12) |
| Udacity, Inc. | Warrant | 9/25/2020 | Common Stock | 486,359 | 218 | 4 | (12) |
| Veem, Inc. | Warrant | 3/31/2022 | Common Stock | 98,428 | 126 | 25 | |
| Worldremit Group Limited | Warrant | 2/11/2021 | Preferred Series D | 77,215 | 129 | 192 | (5)(10)(12)(16) |
| Warrant | 8/27/2021 | Preferred Series E | 1,868 | 26 | 2 | (5)(10)(16) | |
| Total Worldremit Group Limited | 79,083 | 155 | 194 | ||||
| Subtotal: Consumer & Business Services (0.19%)* | 4,248 | 2,639 | |||||
| Drug Delivery | |||||||
| Aerami Therapeutics Holdings, Inc. | Warrant | 9/30/2015 | Common Stock | 110,882 | 74 | — | |
| BioQ Pharma Incorporated | Warrant | 10/27/2014 | Common Stock | 459,183 | 1 | — | |
| PDS Biotechnology Corporation | Warrant | 8/28/2014 | Common Stock | 3,929 | 390 | 1 | (4) |
| Subtotal: Drug Delivery (0.00%)* | 465 | 1 | |||||
| Drug Discovery & Development | |||||||
| Acacia Pharma Inc. | Warrant | 6/29/2018 | Common Stock | 201,330 | 304 | — | (5)(10) |
| ADMA Biologics, Inc. | Warrant | 2/24/2014 | Common Stock | 58,000 | 166 | 10 | (4) |
| Akero Therapeutics, Inc. | Warrant | 6/15/2022 | Common Stock | 18,360 | 56 | 674 | (4)(10) |
| Albireo Pharma, Inc. | Warrant | 6/8/2020 | Common Stock | 5,311 | 61 | 31 | (4)(10) |
| AmplifyBio, LLC | Warrant | 12/27/2022 | Class A Units | 69,239 | 238 | 256 | (15) |
| Portfolio Company · Type ofInvestment · Acquisition Date (4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Warrant | 9/25/2020 | Common Stock | 40,396 | $880 | $1,590 | (4)(10)(12)(16) | |
| Cellarity, Inc. | Warrant | 12/8/2021 | Preferred Series B | 100,000 | 287 | 318 | (15) | |
| Century Therapeutics, Inc. | Warrant | 9/14/2020 | Common Stock | 16,112 | 37 | 3 | (4) | |
| Dermavant Sciences Ltd. | Warrant | 5/31/2019 | Common Stock | 223,642 | 101 | 199 | (5)(10) | |
| enGene, Inc. | Warrant | 12/30/2021 | Preferred Series 3 | 133,692 | 72 | 28 | (5)(10)(12) | |
| Evofem Biosciences, Inc. | Warrant | 6/11/2014 | Common Stock | 520 | 266 | — | (4) | |
| Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.) | Warrant | 2/18/2016 | Common Stock | 200 | 119 | — | (4) | |
| Kineta, Inc. | Warrant | 12/20/2019 | Common Stock | 2,202 | 110 | — | (4) | |
| Kura Oncology, Inc. | Warrant | 11/2/2022 | Common Stock | 14,342 | 88 | 59 | (4)(10)(15) | |
| Madrigal Pharmaceutical, Inc. | Warrant | 5/9/2022 | Common Stock | 10,131 | 177 | 1,977 | (4)(10) | |
| Myovant Sciences, Ltd. | Warrant | 10/16/2017 | Common Stock | 73,710 | 460 | 958 | (4)(5)(10) | |
| Paratek Pharmaceuticals, Inc. | Warrant | 8/1/2018 | Common Stock | 426,866 | 520 | 34 | (4) | |
| Phathom Pharmaceuticals, Inc. | Warrant | 9/17/2021 | Common Stock | 64,687 | 848 | 101 | (4)(10)(12)(15)(16) | |
| Provention Bio, Inc. | Warrant | 9/15/2022 | Common Stock | 111,934 | 281 | 677 | (4) | |
| Redshift Bioanalytics, Inc. | Warrant | 3/23/2022 | Preferred Series E | 475,510 | 20 | 21 | (15) | |
| Scynexis, Inc. | Warrant | 5/14/2021 | Common Stock | 106,035 | 296 | 15 | (4)(12) | |
| TG Therapeutics, Inc. | Warrant | 2/28/2019 | Common Stock | 231,613 | 1,033 | 1,084 | (4)(10)(12) | |
| Tricida, Inc. | Warrant | 3/27/2019 | Common Stock | 31,352 | 280 | 1 | (4) | |
| Valo Health, LLC | Warrant | 6/15/2020 | Common Units | 102,216 | 256 | 127 | ||
| X4 Pharmaceuticals, Inc. | Warrant | 12/9/2022 | Common Stock | 1,392,787 | 510 | 281 | (4) | |
| Subtotal: Drug Discovery & Development (0.60%)* | 7,466 | 8,444 | ||||||
| Electronics & Computer Hardware | ||||||||
| 908 Devices, Inc. | Warrant | 3/15/2017 | Common Stock | 49,078 | 101 | 86 | (4) | |
| Locus Robotics Corp. | Warrant | 6/21/2022 | Common Stock | 8,511 | 34 | 212 | ||
| Skydio, Inc. | Warrant | 11/8/2021 | Common Stock | 622,255 | 557 | 975 | ||
| Subtotal: Electronics & Computer Hardware (0.09%)* | 692 | 1,273 | ||||||
| Healthcare Services, Other | ||||||||
| Vida Health, Inc. | Warrant | 3/28/2022 | Common Stock | 100,618 | 114 | 14 | ||
| Subtotal: Healthcare Services, Other (0.00%)* | 114 | 14 | ||||||
| Information Services | ||||||||
| Capella Space Corp. | Warrant | 10/21/2021 | Common Stock | 176,200 | 207 | 114 | (15) | |
| INMOBI Inc. | Warrant | 11/19/2014 | Common Stock | 65,587 | 82 | — | (5)(10) | |
| NetBase Solutions, Inc. | Warrant | 8/22/2017 | Preferred Series 1 | 60,000 | 356 | 380 | ||
| Signal Media Limited | Warrant | 6/29/2022 | Common Stock | 94,857 | 35 | 15 | (5)(10) | |
| Subtotal: Information Services (0.04%)* | 680 | 509 | ||||||
| Manufacturing Technology | ||||||||
| Bright Machines, Inc. | Warrant | 3/31/2022 | Common Stock | 392,308 | 537 | 1,154 | ||
| MacroFab, Inc. | Warrant | 3/23/2022 | Common Stock | 1,111,111 | 528 | 1,202 | ||
| Portfolio Company · Type ofInvestment · Acquisition Date (4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Xometry, Inc. | Warrant | 5/9/2018 | Common Stock | 87,784 | $47 | $1,800 | (4) | |
| Subtotal: Manufacturing Technology (0.30%)* | 1,112 | 4,156 | ||||||
| Media/Content/Info | ||||||||
| Fever Labs, Inc. | Warrant | 12/30/2022 | Preferred Series E-1 | 221,622 | 35 | 35 | ||
| Subtotal: Media/Content/Info (0.00%)* | 35 | 35 | ||||||
| Medical Devices & Equipment | ||||||||
| Aspire Bariatrics, Inc. | Warrant | 1/28/2015 | Common Stock | 22,572 | 455 | — | ||
| Flowonix Medical Incorporated | Warrant | 11/3/2014 | Preferred Series AA | 110,946 | 362 | — | ||
| Warrant | 9/21/2018 | Preferred Series BB | 725,806 | 351 | — | |||
| Total Flowonix Medical Incorporated | 836,752 | 713 | — | |||||
| Intuity Medical, Inc. | Warrant | 12/29/2017 | Preferred Series B-1 | 3,076,323 | 294 | 54 | ||
| Lucira Health, Inc. | Warrant | 2/4/2022 | Common Stock | 59,642 | 110 | — | (4) | |
| Outset Medical, Inc. | Warrant | 9/27/2013 | Common Stock | 62,794 | 401 | 864 | (4) | |
| Tela Bio, Inc. | Warrant | 3/31/2017 | Common Stock | 15,712 | 61 | 1 | (4) | |
| Subtotal: Medical Devices & Equipment (0.07%)* | 2,034 | 919 | ||||||
| Semiconductors | ||||||||
| Achronix Semiconductor Corporation | Warrant | 6/26/2015 | Preferred Series D-2 | 750,000 | 99 | 524 | ||
| Fungible, Inc. | Warrant | 12/16/2021 | Common Stock | 800,000 | 751 | — | (15) | |
| Subtotal: Semiconductors (0.04%)* | 850 | 524 | ||||||
| Software | ||||||||
| Aria Systems, Inc. | Warrant | 5/22/2015 | Preferred Series G | 231,535 | 74 | — | ||
| Automation Anywhere, Inc. | Warrant | 9/23/2022 | Common Stock | 254,778 | 448 | 365 | ||
| Bitsight Technologies, Inc. | Warrant | 11/18/2020 | Common Stock | 29,691 | 284 | 398 | ||
| Brain Corporation | Warrant | 10/4/2021 | Common Stock | 194,629 | 165 | 61 | (15) | |
| CloudBolt Software, Inc. | Warrant | 9/30/2020 | Common Stock | 211,342 | 117 | 1 | ||
| Cloudian, Inc. | Warrant | 11/6/2018 | Common Stock | 477,454 | 71 | 14 | ||
| Cloudpay, Inc. | Warrant | 4/10/2018 | Preferred Series B | 6,763 | 54 | 400 | (5)(10) | |
| Convoy, Inc. | Warrant | 3/30/2022 | Common Stock | 165,456 | 974 | 364 | (16) | |
| Couchbase, Inc. | Warrant | 4/25/2019 | Common Stock | 105,350 | 462 | 488 | (4) | |
| Cutover, Inc. | Warrant | 9/21/2022 | Common Stock | 102,898 | 26 | 19 | (5)(10)(12) | |
| Dashlane, Inc. | Warrant | 3/11/2019 | Common Stock | 453,641 | 353 | 168 | ||
| Delphix Corp. | Warrant | 10/8/2019 | Common Stock | 718,898 | 1,594 | 2,657 | ||
| Demandbase, Inc. | Warrant | 8/2/2021 | Common Stock | 727,047 | 545 | 180 | ||
| DNAnexus, Inc. | Warrant | 3/21/2014 | Preferred Series C | 909,091 | 97 | 131 | ||
| DroneDeploy, Inc. | Warrant | 6/30/2022 | Common Stock | 95,911 | 278 | 300 | ||
| Eigen Technologies Ltd. | Warrant | 4/13/2022 | Common Stock | 522 | 8 | 6 | (5)(10) | |
| Elation Health, Inc. | Warrant | 9/12/2022 | Common Stock | 362,837 | 583 | 382 | ||
| Esme Learning Solutions, Inc. | Warrant | 1/27/2022 | Common Stock | 56,765 | 198 | — | ||
| Evernote Corporation | Warrant | 9/30/2016 | Common Stock | 62,500 | 107 | 6 | ||
| Portfolio Company | Type ofInvestment | Acquisition Date (4) | Series (3) | Shares | Cost (2) | Value | Footnotes |
|---|---|---|---|---|---|---|---|
| First Insight, Inc. | Warrant | 5/10/2018 | Preferred Series B | 75,917 | $96 | $39 | |
| Fulfil Solutions, Inc. | Warrant | 7/29/2022 | Common Stock | 84,995 | 325 | 314 | |
| Lightbend, Inc. | Warrant | 2/14/2018 | Preferred Series D | 89,685 | 131 | 1 | |
| Mixpanel, Inc. | Warrant | 9/30/2020 | Common Stock | 82,362 | 252 | 225 | |
| Nuvolo Technologies Corporation | Warrant | 3/29/2019 | Common Stock | 70,000 | 172 | 175 | (12) |
| Poplicus, Inc. | Warrant | 5/28/2014 | Common Stock | 132,168 | — | — | |
| Reltio, Inc. | Warrant | 6/30/2020 | Common Stock | 69,120 | 215 | 298 | |
| SignPost, Inc. | Warrant | 1/13/2016 | Series Junior 1 Preferred | 474,019 | 314 | — | |
| SingleStore, Inc. | Warrant | 4/28/2020 | Preferred Series D | 312,596 | 103 | 426 | |
| Tact.ai Technologies, Inc. | Warrant | 2/13/2020 | Common Stock | 1,041,667 | 206 | 69 | |
| The Faction Group LLC | Warrant | 11/3/2014 | Preferred Series AA | 8,076 | 234 | 436 | |
| VideoAmp, Inc. | Warrant | 1/21/2022 | Common Stock | 152,048 | 1,275 | 321 | (15) |
| Subtotal: Software (0.59%)* | 9,761 | 8,244 | |||||
| Surgical Devices | |||||||
| Gynesonics, Inc. | Warrant | 1/16/2013 | Preferred Series C | 16,835 | 7 | — | |
| TransMedics Group, Inc. | Warrant | 9/11/2015 | Common Stock | 14,440 | 39 | 492 | (4) |
| Subtotal: Surgical Devices (0.04%)* | 46 | 492 | |||||
| Sustainable and Renewable Technology | |||||||
| Ampion, PBC | Warrant | 4/15/2022 | Common Stock | 18,472 | 52 | 44 | |
| Fulcrum Bioenergy, Inc. | Warrant | 4/30/2013 | Preferred Series C-1 | 93,632 | 64 | 275 | |
| Halio, Inc. | Warrant | 4/22/2014 | Preferred Series A | 325,000 | 155 | 126 | |
| Warrant | 4/7/2015 | Preferred Series B | 131,883 | 63 | 43 | ||
| Total Halio, Inc. | 456,883 | 218 | 169 | ||||
| IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.) | Warrant | 6/20/2013 | Preferred Series D | 471,327 | 120 | — | |
| Polyera Corporation | Warrant | 3/24/2015 | Preferred Series C | 150,036 | 269 | — | |
| Subtotal: Sustainable and Renewable Technology (0.03%)* | 723 | 488 | |||||
| Total: Warrant Investments (2.19%)* | $30,964 | $30,646 | |||||
| Total: Investments in Securities (211.21%)* | $3,002,197 | $2,960,062 | |||||
| Investment Funds & Vehicles Investments | |||||||
| Drug Discovery & Development | |||||||
| Forbion Growth Opportunities Fund I C.V. | Investment Funds & Vehicles | 11/16/2020 | $2,699 | $3,080 | (5)(10)(17) | ||
| Forbion Growth Opportunities Fund II C.V. | Investment Funds & Vehicles | 6/23/2022 | 419 | 438 | (5)(10)(17) | ||
| Subtotal: Drug Discovery & Development (0.25%)* | $3,118 | $3,518 | |||||
| Portfolio Company · Type ofInvestment · Acquisition Date (4) · Series (3) · Shares · Cost (2) · Value · Footnotes | ||||||||
|---|---|---|---|---|---|---|---|---|
| Software | ||||||||
| Liberty Zim Co-Invest L.P. | Investment Funds & Vehicles | 7/21/2022 | $381 | $375 | (5)(10) | |||
| Subtotal: Software (0.03%)* | 381 | 375 | ||||||
| Total: Investment Funds & Vehicles Investments (0.28%)* | $3,499 | $3,893 | ||||||
| Total: Investments (211.49%)* | $3,005,696 | $2,963,955 | ||||||
*Value as a percent of net assets. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
(1)Interest rate PRIME represents 7.50% as of December 31, 2022. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent,4.40%,4.77%, and 5.14%, respectively, as of December 31, 2022.
(2)Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $72.2 million, $112.0 million, and $39.8 million, respectively. The tax cost of investments is $3.0 billion.
(3)Preferred and common stock, warrants, and equity interests are generally non-income producing.
(4)Except for warrants in 27 publicly traded companies and common stock in 43 publicly traded companies, all investments are restricted as of December 31, 2022 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s Board.
(5)Non-U.S. company or the company’s principal place of business is outside the United States.
(6)[Reserved]
(7)Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
(8)Debt is on non-accrual status as of December 31, 2022, and is therefore considered non-income producing. Note that only the PIK portion is on non-accrual for the Company’s debt investment in Tectura Corporation and Pineapple Energy LLC.
(9)Denotes that all or a portion of the debt investment is convertible debt.
(10)Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
(11)Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
(12)Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
(13)Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
(14)Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
(15)Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
(16)Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2022.
(17)Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2022. Refer to “Note 11 — Commitments and Contingencies”.
(18)Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
(19)Denotes second lien senior secured debt.
(20)Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.
(21)Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock in portfolio company Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2022, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $3.0 million.
(22)Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.4 million, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.